000001154412/312021Q1FALSE1.5P3Y00000115442022-01-012022-03-310000011544wrb:SubordinatedDebenturesDue20585.70Member2022-01-012022-03-310000011544wrb:SubordinatedDebenturesDue2059510Member2022-01-012022-03-310000011544wrb:SubordinatedDebenturesDue2060425Member2022-01-012022-03-310000011544wrb:SubordinatedDebenturesDue20614125Member2022-01-012022-03-3100000115442022-05-02xbrli:shares00000115442022-03-31iso4217:USD00000115442021-12-31iso4217:USDxbrli:shares00000115442021-01-012021-03-310000011544us-gaap:CommonStockMember2021-12-310000011544us-gaap:CommonStockMember2020-12-310000011544us-gaap:AdditionalPaidInCapitalMember2021-12-310000011544us-gaap:AdditionalPaidInCapitalMember2020-12-310000011544us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310000011544us-gaap:AdditionalPaidInCapitalMember2021-01-012021-03-310000011544us-gaap:AdditionalPaidInCapitalMember2022-03-310000011544us-gaap:AdditionalPaidInCapitalMember2021-03-310000011544us-gaap:RetainedEarningsMember2021-12-310000011544us-gaap:RetainedEarningsMember2020-12-310000011544us-gaap:RetainedEarningsMember2022-01-012022-03-310000011544us-gaap:RetainedEarningsMember2021-01-012021-03-310000011544us-gaap:RetainedEarningsMember2022-03-310000011544us-gaap:RetainedEarningsMember2021-03-310000011544us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2021-12-310000011544us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2020-12-310000011544us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2022-01-012022-03-310000011544us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2021-01-012021-03-310000011544us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2022-03-310000011544us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2021-03-310000011544us-gaap:AccumulatedTranslationAdjustmentMember2021-12-310000011544us-gaap:AccumulatedTranslationAdjustmentMember2020-12-310000011544us-gaap:AccumulatedTranslationAdjustmentMember2022-01-012022-03-310000011544us-gaap:AccumulatedTranslationAdjustmentMember2021-01-012021-03-310000011544us-gaap:AccumulatedTranslationAdjustmentMember2022-03-310000011544us-gaap:AccumulatedTranslationAdjustmentMember2021-03-310000011544us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-310000011544us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-03-310000011544us-gaap:TreasuryStockMember2021-12-310000011544us-gaap:TreasuryStockMember2020-12-310000011544us-gaap:TreasuryStockMember2022-01-012022-03-310000011544us-gaap:TreasuryStockMember2021-01-012021-03-310000011544us-gaap:TreasuryStockMember2022-03-310000011544us-gaap:TreasuryStockMember2021-03-310000011544us-gaap:NoncontrollingInterestMember2021-12-310000011544us-gaap:NoncontrollingInterestMember2020-12-310000011544us-gaap:NoncontrollingInterestMember2022-01-012022-03-310000011544us-gaap:NoncontrollingInterestMember2021-01-012021-03-310000011544us-gaap:NoncontrollingInterestMember2022-03-310000011544us-gaap:NoncontrollingInterestMember2021-03-3100000115442020-12-3100000115442021-03-3100000115442022-03-232022-03-23xbrli:pure0000011544wrb:PlacematAndRugManufacturingBusinessMember2022-03-310000011544wrb:PlacematAndRugManufacturingBusinessMember2022-03-012022-03-310000011544us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-12-310000011544us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310000011544us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-01-012022-03-310000011544us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-310000011544us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-03-310000011544us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-01-012022-03-310000011544us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedTranslationAdjustmentMember2022-01-012022-03-310000011544us-gaap:AccumulatedOtherComprehensiveIncomeMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-310000011544us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-12-310000011544us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310000011544us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-01-012021-03-310000011544us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-03-310000011544us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-03-310000011544us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-01-012021-03-310000011544us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedTranslationAdjustmentMember2021-01-012021-03-310000011544us-gaap:AccumulatedOtherComprehensiveIncomeMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2021-01-012021-03-310000011544us-gaap:USStatesAndPoliticalSubdivisionsMember2022-03-310000011544us-gaap:ResidentialMortgageBackedSecuritiesMember2022-03-310000011544us-gaap:USTreasuryAndGovernmentMember2022-03-310000011544wrb:SpecialRevenueMember2022-03-310000011544us-gaap:SovereignDebtStateGovernmentUnspecifiedMember2022-03-310000011544us-gaap:RevenueSubjectToRefundMember2022-03-310000011544us-gaap:CorporationMember2022-03-310000011544us-gaap:SovereignDebtLocalGovernmentUnspecifiedMember2022-03-310000011544us-gaap:CommercialMortgageBackedSecuritiesMember2022-03-310000011544us-gaap:MortgageBackedSecuritiesMember2022-03-310000011544us-gaap:AssetBackedSecuritiesMember2022-03-310000011544srt:IndustrialPropertyMember2022-03-310000011544us-gaap:DomesticCorporateDebtSecuritiesMember2022-03-310000011544us-gaap:PublicUtilityBondsMember2022-03-310000011544us-gaap:OtherAggregatedInvestmentsMember2022-03-310000011544us-gaap:CorporateDebtSecuritiesMember2022-03-310000011544us-gaap:ForeignGovernmentDebtSecuritiesMember2022-03-310000011544us-gaap:USStatesAndPoliticalSubdivisionsMember2021-12-310000011544us-gaap:ResidentialMortgageBackedSecuritiesMember2021-12-310000011544us-gaap:USTreasuryAndGovernmentMember2021-12-310000011544wrb:SpecialRevenueMember2021-12-310000011544us-gaap:SovereignDebtStateGovernmentUnspecifiedMember2021-12-310000011544us-gaap:RevenueSubjectToRefundMember2021-12-310000011544us-gaap:CorporationMember2021-12-310000011544us-gaap:SovereignDebtLocalGovernmentUnspecifiedMember2021-12-310000011544us-gaap:CommercialMortgageBackedSecuritiesMember2021-12-310000011544us-gaap:MortgageBackedSecuritiesMember2021-12-310000011544us-gaap:AssetBackedSecuritiesMember2021-12-310000011544srt:IndustrialPropertyMember2021-12-310000011544us-gaap:DomesticCorporateDebtSecuritiesMember2021-12-310000011544us-gaap:PublicUtilityBondsMember2021-12-310000011544us-gaap:OtherAggregatedInvestmentsMember2021-12-310000011544us-gaap:CorporateDebtSecuritiesMember2021-12-310000011544us-gaap:ForeignGovernmentDebtSecuritiesMember2021-12-310000011544us-gaap:ForeignGovernmentDebtSecuritiesMember2020-12-310000011544us-gaap:CorporateDebtSecuritiesMember2020-12-310000011544us-gaap:ForeignGovernmentDebtSecuritiesMember2022-01-012022-03-310000011544us-gaap:CorporateDebtSecuritiesMember2022-01-012022-03-310000011544us-gaap:ForeignGovernmentDebtSecuritiesMember2021-01-012021-03-310000011544us-gaap:CorporateDebtSecuritiesMember2021-01-012021-03-310000011544us-gaap:ForeignGovernmentDebtSecuritiesMember2021-03-310000011544us-gaap:CorporateDebtSecuritiesMember2021-03-310000011544us-gaap:EquitySecuritiesMember2022-01-012022-03-310000011544us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:CommonStockMember2022-03-310000011544us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:CommonStockMember2022-01-012022-03-310000011544us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:CommonStockMember2022-03-310000011544us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:PreferredStockMember2022-03-310000011544us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:PreferredStockMember2022-01-012022-03-310000011544us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:PreferredStockMember2022-03-310000011544us-gaap:EstimateOfFairValueFairValueDisclosureMember2022-03-310000011544us-gaap:EstimateOfFairValueFairValueDisclosureMember2022-01-012022-03-310000011544us-gaap:CarryingReportedAmountFairValueDisclosureMember2022-03-310000011544us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:CommonStockMember2021-12-310000011544us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:CommonStockMember2021-01-012021-12-310000011544us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:CommonStockMember2021-12-310000011544us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:PreferredStockMember2021-12-310000011544us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:PreferredStockMember2021-01-012021-12-310000011544us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:PreferredStockMember2021-12-310000011544us-gaap:EstimateOfFairValueFairValueDisclosureMember2021-12-310000011544us-gaap:EstimateOfFairValueFairValueDisclosureMember2021-01-012021-12-310000011544us-gaap:CarryingReportedAmountFairValueDisclosureMember2021-12-310000011544us-gaap:OptionMemberus-gaap:ShortMember2022-03-310000011544wrb:FixedMaturitySecuritiesCashCashEquivalentsandLoansReceivableMember2022-01-012022-03-310000011544wrb:FixedMaturitySecuritiesCashCashEquivalentsandLoansReceivableMember2021-01-012021-03-310000011544us-gaap:EquityMethodInvestmentsMember2022-01-012022-03-310000011544us-gaap:EquityMethodInvestmentsMember2021-01-012021-03-310000011544wrb:ArbitrageTradingAccountMember2022-01-012022-03-310000011544wrb:ArbitrageTradingAccountMember2021-01-012021-03-310000011544us-gaap:EquitySecuritiesMember2022-01-012022-03-310000011544us-gaap:EquitySecuritiesMember2021-01-012021-03-310000011544us-gaap:RealEstateMember2022-01-012022-03-310000011544us-gaap:RealEstateMember2021-01-012021-03-310000011544wrb:FinancialServicesFundsMember2022-03-310000011544wrb:FinancialServicesFundsMember2021-12-310000011544wrb:FinancialServicesFundsMember2022-01-012022-03-310000011544wrb:FinancialServicesFundsMember2021-01-012021-03-310000011544wrb:TransportationFundsMember2022-03-310000011544wrb:TransportationFundsMember2021-12-310000011544wrb:TransportationFundsMember2022-01-012022-03-310000011544wrb:TransportationFundsMember2021-01-012021-03-310000011544us-gaap:RealEstateFundsMember2022-03-310000011544us-gaap:RealEstateFundsMember2021-12-310000011544us-gaap:RealEstateFundsMember2022-01-012022-03-310000011544us-gaap:RealEstateFundsMember2021-01-012021-03-310000011544wrb:EnergyFundsMember2022-03-310000011544wrb:EnergyFundsMember2021-12-310000011544wrb:EnergyFundsMember2022-01-012022-03-310000011544wrb:EnergyFundsMember2021-01-012021-03-310000011544wrb:OtherFundsMember2022-03-310000011544wrb:OtherFundsMember2021-12-310000011544wrb:OtherFundsMember2022-01-012022-03-310000011544wrb:OtherFundsMember2021-01-012021-03-310000011544wrb:LifsonReMember2022-01-012022-03-310000011544wrb:LifsonReMember2021-01-012021-03-310000011544us-gaap:CommercialRealEstatePortfolioSegmentMember2022-03-310000011544us-gaap:CommercialRealEstatePortfolioSegmentMember2021-12-310000011544us-gaap:CommercialPortfolioSegmentMember2022-03-310000011544us-gaap:CommercialPortfolioSegmentMember2021-12-310000011544us-gaap:CommercialPortfolioSegmentMember2022-01-012022-03-310000011544us-gaap:CommercialRealEstatePortfolioSegmentMember2020-12-310000011544us-gaap:CommercialPortfolioSegmentMember2020-12-310000011544us-gaap:CommercialRealEstatePortfolioSegmentMember2022-01-012022-03-310000011544us-gaap:CommercialRealEstatePortfolioSegmentMember2021-01-012021-03-310000011544us-gaap:CommercialPortfolioSegmentMember2021-01-012021-03-310000011544us-gaap:CommercialRealEstatePortfolioSegmentMember2021-03-310000011544us-gaap:CommercialPortfolioSegmentMember2021-03-310000011544us-gaap:DebtSecuritiesMember2022-01-012022-03-310000011544us-gaap:DebtSecuritiesMember2021-01-012021-03-310000011544wrb:DebtSecuritiesPreviouslyImpairedMember2022-01-012022-03-310000011544wrb:DebtSecuritiesPreviouslyImpairedMember2021-01-012021-03-310000011544us-gaap:EquityMethodInvestmentsMember2022-01-012022-03-310000011544us-gaap:EquityMethodInvestmentsMember2021-01-012021-03-310000011544us-gaap:OtherDebtSecuritiesMember2022-01-012022-03-310000011544us-gaap:OtherDebtSecuritiesMember2021-01-012021-03-310000011544us-gaap:DebtSecuritiesMember2022-03-310000011544us-gaap:DebtSecuritiesMember2021-12-310000011544us-gaap:ForeignGovernmentDebtMemberwrb:NoninvestmentGradeInvestmentsatLossLessthan5MillionMember2022-03-31wrb:position0000011544us-gaap:CorporateDebtSecuritiesMemberwrb:NoninvestmentGradeInvestmentsatLossLessthan5MillionMember2022-03-310000011544wrb:NoninvestmentGradeInvestmentsatLossLessthan5MillionMemberus-gaap:USStatesAndPoliticalSubdivisionsMember2022-03-310000011544us-gaap:MortgageBackedSecuritiesMemberwrb:NoninvestmentGradeInvestmentsatLossLessthan5MillionMember2022-03-310000011544us-gaap:AssetBackedSecuritiesMemberwrb:NoninvestmentGradeInvestmentsatLossLessthan5MillionMember2022-03-310000011544wrb:NoninvestmentGradeInvestmentsatLossLessthan5MillionMember2022-03-310000011544us-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueMeasurementsRecurringMember2022-03-310000011544us-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-03-310000011544us-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-03-310000011544us-gaap:FairValueInputsLevel3Memberus-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueMeasurementsRecurringMember2022-03-310000011544us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USStatesAndPoliticalSubdivisionsMember2022-03-310000011544us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:USStatesAndPoliticalSubdivisionsMember2022-03-310000011544us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USStatesAndPoliticalSubdivisionsMember2022-03-310000011544us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USStatesAndPoliticalSubdivisionsMember2022-03-310000011544us-gaap:FairValueMeasurementsRecurringMemberus-gaap:MortgageBackedSecuritiesMember2022-03-310000011544us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:MortgageBackedSecuritiesMember2022-03-310000011544us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MortgageBackedSecuritiesMember2022-03-310000011544us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MortgageBackedSecuritiesMember2022-03-310000011544us-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2022-03-310000011544us-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-03-310000011544us-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-03-310000011544us-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-03-310000011544us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2022-03-310000011544us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:CorporateDebtSecuritiesMember2022-03-310000011544us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2022-03-310000011544us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2022-03-310000011544us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignGovernmentDebtSecuritiesMember2022-03-310000011544us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:ForeignGovernmentDebtSecuritiesMember2022-03-310000011544us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignGovernmentDebtSecuritiesMember2022-03-310000011544us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignGovernmentDebtSecuritiesMember2022-03-310000011544us-gaap:FairValueMeasurementsRecurringMember2022-03-310000011544us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-03-310000011544us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-03-310000011544us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-03-310000011544us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommonStockMember2022-03-310000011544us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:CommonStockMember2022-03-310000011544us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommonStockMember2022-03-310000011544us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommonStockMember2022-03-310000011544us-gaap:PreferredStockMemberus-gaap:FairValueMeasurementsRecurringMember2022-03-310000011544us-gaap:PreferredStockMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-03-310000011544us-gaap:PreferredStockMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2022-03-310000011544us-gaap:FairValueInputsLevel3Memberus-gaap:PreferredStockMemberus-gaap:FairValueMeasurementsRecurringMember2022-03-310000011544us-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000011544us-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2021-12-310000011544us-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000011544us-gaap:FairValueInputsLevel3Memberus-gaap:USTreasuryAndGovernmentMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000011544us-gaap:FairValueMeasurementsRecurringMemberus-gaap:USStatesAndPoliticalSubdivisionsMember2021-12-310000011544us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:USStatesAndPoliticalSubdivisionsMember2021-12-310000011544us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USStatesAndPoliticalSubdivisionsMember2021-12-310000011544us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USStatesAndPoliticalSubdivisionsMember2021-12-310000011544us-gaap:FairValueMeasurementsRecurringMemberus-gaap:MortgageBackedSecuritiesMember2021-12-310000011544us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:MortgageBackedSecuritiesMember2021-12-310000011544us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MortgageBackedSecuritiesMember2021-12-310000011544us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:MortgageBackedSecuritiesMember2021-12-310000011544us-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000011544us-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2021-12-310000011544us-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000011544us-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000011544us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2021-12-310000011544us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:CorporateDebtSecuritiesMember2021-12-310000011544us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2021-12-310000011544us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2021-12-310000011544us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignGovernmentDebtSecuritiesMember2021-12-310000011544us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:ForeignGovernmentDebtSecuritiesMember2021-12-310000011544us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignGovernmentDebtSecuritiesMember2021-12-310000011544us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignGovernmentDebtSecuritiesMember2021-12-310000011544us-gaap:FairValueMeasurementsRecurringMember2021-12-310000011544us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2021-12-310000011544us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000011544us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000011544us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommonStockMember2021-12-310000011544us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:CommonStockMember2021-12-310000011544us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommonStockMember2021-12-310000011544us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommonStockMember2021-12-310000011544us-gaap:PreferredStockMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000011544us-gaap:PreferredStockMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2021-12-310000011544us-gaap:PreferredStockMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000011544us-gaap:FairValueInputsLevel3Memberus-gaap:PreferredStockMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310000011544us-gaap:FairValueInputsLevel3Memberus-gaap:CommonStockMember2021-12-310000011544us-gaap:FairValueInputsLevel3Memberus-gaap:CommonStockMember2022-01-012022-03-310000011544us-gaap:FairValueInputsLevel3Memberus-gaap:CommonStockMember2022-03-310000011544us-gaap:FairValueInputsLevel3Memberus-gaap:PreferredStockMember2021-12-310000011544us-gaap:FairValueInputsLevel3Memberus-gaap:PreferredStockMember2022-01-012022-03-310000011544us-gaap:FairValueInputsLevel3Memberus-gaap:PreferredStockMember2022-03-310000011544us-gaap:FairValueInputsLevel3Memberus-gaap:EquitySecuritiesMember2021-12-310000011544us-gaap:FairValueInputsLevel3Memberus-gaap:EquitySecuritiesMember2022-01-012022-03-310000011544us-gaap:FairValueInputsLevel3Memberus-gaap:EquitySecuritiesMember2022-03-310000011544us-gaap:FairValueInputsLevel3Memberus-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember2021-12-310000011544us-gaap:FairValueInputsLevel3Memberus-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember2022-01-012022-03-310000011544us-gaap:FairValueInputsLevel3Memberus-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember2022-03-310000011544us-gaap:FairValueInputsLevel3Member2021-12-310000011544us-gaap:FairValueInputsLevel3Member2022-01-012022-03-310000011544us-gaap:FairValueInputsLevel3Member2022-03-310000011544us-gaap:FairValueInputsLevel3Memberus-gaap:CorporateDebtSecuritiesMember2020-12-310000011544us-gaap:FairValueInputsLevel3Memberus-gaap:CorporateDebtSecuritiesMember2021-01-012021-06-300000011544us-gaap:FairValueInputsLevel3Memberus-gaap:CorporateDebtSecuritiesMember2021-12-310000011544us-gaap:FairValueInputsLevel3Memberus-gaap:DebtSecuritiesMember2020-12-310000011544us-gaap:FairValueInputsLevel3Memberus-gaap:DebtSecuritiesMember2021-01-012021-06-300000011544us-gaap:FairValueInputsLevel3Memberus-gaap:DebtSecuritiesMember2021-12-310000011544us-gaap:FairValueInputsLevel3Memberus-gaap:CommonStockMember2020-12-310000011544us-gaap:FairValueInputsLevel3Memberus-gaap:CommonStockMember2021-01-012021-06-300000011544us-gaap:FairValueInputsLevel3Memberus-gaap:PreferredStockMember2020-12-310000011544us-gaap:FairValueInputsLevel3Memberus-gaap:PreferredStockMember2021-01-012021-06-300000011544us-gaap:FairValueInputsLevel3Memberus-gaap:EquitySecuritiesMember2020-12-310000011544us-gaap:FairValueInputsLevel3Memberus-gaap:EquitySecuritiesMember2021-01-012021-06-300000011544us-gaap:FairValueInputsLevel3Memberus-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember2020-12-310000011544us-gaap:FairValueInputsLevel3Memberus-gaap:TradingAssetsExcludingDebtAndEquitySecuritiesMember2021-01-012021-06-300000011544us-gaap:FairValueInputsLevel3Member2020-12-310000011544us-gaap:FairValueInputsLevel3Member2021-01-012021-06-3000000115442021-01-012021-06-300000011544wrb:InsuranceDomesticSegmentMember2022-03-310000011544wrb:ReinsuranceandMonolineExcessSegmentMember2022-03-310000011544wrb:InsuranceDomesticSegmentMember2022-01-012022-03-310000011544wrb:ReinsuranceandMonolineExcessSegmentMember2022-01-012022-03-310000011544wrb:InsuranceDomesticSegmentMember2021-01-012021-03-310000011544wrb:ReinsuranceandMonolineExcessSegmentMember2021-01-012021-03-310000011544us-gaap:RestrictedStockUnitsRSUMembersrt:MinimumMember2022-01-012022-03-310000011544us-gaap:RestrictedStockUnitsRSUMembersrt:MaximumMember2022-01-012022-03-310000011544us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-03-310000011544us-gaap:RestrictedStockUnitsRSUMember2021-01-012021-03-31wrb:segment0000011544wrb:InsuranceDomesticSegmentMemberus-gaap:OperatingSegmentsMember2022-01-012022-03-310000011544wrb:ReinsuranceandMonolineExcessSegmentMemberus-gaap:OperatingSegmentsMember2022-01-012022-03-310000011544srt:ConsolidationEliminationsMember2022-01-012022-03-310000011544wrb:NetInvestmentGainsSegmentMember2022-01-012022-03-310000011544wrb:InsuranceDomesticSegmentMemberus-gaap:OperatingSegmentsMember2021-01-012021-03-310000011544wrb:ReinsuranceandMonolineExcessSegmentMemberus-gaap:OperatingSegmentsMember2021-01-012021-03-310000011544srt:ConsolidationEliminationsMember2021-01-012021-03-310000011544wrb:NetInvestmentGainsSegmentMember2021-01-012021-03-310000011544wrb:InsuranceInternationalSegmentMemberus-gaap:OperatingSegmentsMember2022-01-012022-03-310000011544wrb:InsuranceInternationalSegmentMemberus-gaap:OperatingSegmentsMember2021-01-012021-03-310000011544wrb:ReinsuranceInternationalMemberus-gaap:OperatingSegmentsMember2022-01-012022-03-310000011544wrb:ReinsuranceInternationalMemberus-gaap:OperatingSegmentsMember2021-01-012021-03-310000011544wrb:InsuranceDomesticSegmentMemberus-gaap:OperatingSegmentsMember2022-03-310000011544wrb:InsuranceDomesticSegmentMemberus-gaap:OperatingSegmentsMember2021-12-310000011544wrb:ReinsuranceandMonolineExcessSegmentMemberus-gaap:OperatingSegmentsMember2022-03-310000011544wrb:ReinsuranceandMonolineExcessSegmentMemberus-gaap:OperatingSegmentsMember2021-12-310000011544srt:ConsolidationEliminationsMember2022-03-310000011544srt:ConsolidationEliminationsMember2021-12-310000011544wrb:InsuranceDomesticSegmentMemberwrb:OtherInsuranceLiabilitiesMember2022-01-012022-03-310000011544wrb:InsuranceDomesticSegmentMemberwrb:OtherInsuranceLiabilitiesMember2021-01-012021-03-310000011544wrb:ShortTailLinesMemberwrb:InsuranceDomesticSegmentMember2022-01-012022-03-310000011544wrb:ShortTailLinesMemberwrb:InsuranceDomesticSegmentMember2021-01-012021-03-310000011544wrb:WorkersCompensationMemberwrb:InsuranceDomesticSegmentMember2022-01-012022-03-310000011544wrb:WorkersCompensationMemberwrb:InsuranceDomesticSegmentMember2021-01-012021-03-310000011544wrb:CommercialAutomobileMemberwrb:InsuranceDomesticSegmentMember2022-01-012022-03-310000011544wrb:CommercialAutomobileMemberwrb:InsuranceDomesticSegmentMember2021-01-012021-03-310000011544wrb:ProductsLiabilityMemberwrb:InsuranceDomesticSegmentMember2022-01-012022-03-310000011544wrb:ProductsLiabilityMemberwrb:InsuranceDomesticSegmentMember2021-01-012021-03-310000011544wrb:ReinsuranceandMonolineExcessSegmentMemberwrb:CasualtyMember2022-01-012022-03-310000011544wrb:ReinsuranceandMonolineExcessSegmentMemberwrb:CasualtyMember2021-01-012021-03-310000011544wrb:MonolineExcessMemberwrb:ReinsuranceandMonolineExcessSegmentMember2022-01-012022-03-310000011544wrb:MonolineExcessMemberwrb:ReinsuranceandMonolineExcessSegmentMember2021-01-012021-03-310000011544wrb:ReinsuranceandMonolineExcessSegmentMemberwrb:PropertyMember2022-01-012022-03-310000011544wrb:ReinsuranceandMonolineExcessSegmentMemberwrb:PropertyMember2021-01-012021-03-310000011544us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:SubsequentEventMember2022-04-010000011544us-gaap:LineOfCreditMemberus-gaap:LetterOfCreditMemberus-gaap:SubsequentEventMember2022-04-01
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-Q
(Mark one)
|
|
|
|
|
|
☒ |
QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934 |
For the Quarterly Period Ended March 31, 2022
or
|
|
|
|
|
|
☐
|
Transition Report Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934. |
For the Transition Period from
to
.
|
|
|
|
|
|
Commission File Number
|
1-15202
|
W. R. BERKLEY CORPORATION
(Exact name of registrant as specified in its charter)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Delaware |
|
22-1867895 |
(State or other jurisdiction of
incorporation or organization) |
|
(I.R.S. Employer Identification No.) |
|
|
|
475 Steamboat Road |
Greenwich |
Connecticut |
06830 |
(Address of principal executive offices) |
|
|
(Zip Code) |
(Registrant’s telephone number, including area code)
|
|
|
|
|
|
|
|
|
|
None |
|
Former name, former address and former fiscal year, if changed
since last report.
|
Securities registered pursuant to Section 12(b) of the
Act:
|
|
|
|
|
|
|
|
|
Title |
Trading Symbol |
Name |
|
|
|
Common Stock, par value $.20 per share |
WRB |
New York Stock Exchange |
|
|
|
|
|
|
5.700% Subordinated Debentures due 2058 |
WRB-PE |
New York Stock Exchange |
5.100% Subordinated Debentures due 2059 |
WRB-PF |
New York Stock Exchange |
4.250% Subordinated Debentures due 2060 |
WRB-PG |
New York Stock Exchange |
4.125% Subordinated Debentures due 2061 |
WRB-PH |
New York Stock Exchange |
Indicate by check mark whether the registrant (1) has filed
all reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months
(or for such shorter period that the registrant was required to
file such reports), and (2) has been subject to such filing
requirements for the past 90 days. Yes
☒
No
☐
Indicate by check mark whether the registrant has submitted
electronically every Interactive Data File required to be submitted
pursuant to Rule 405 of Regulation S-T (§232.405 of this
chapter) during the preceding 12 months (or for such shorter
period that the registrant was required to submit such files).
Yes
☒
No
☐
Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, a non-accelerated filer, a
smaller reporting company, or an emerging growth company. See the
definitions of “large accelerated filer,” “accelerated filer,”
“smaller reporting company,” and “emerging growth company” in
Rule 12b-2 of the Exchange Act.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Large accelerated filer |
☒
|
|
Accelerated filer |
☐ |
Non-accelerated filer |
☐ |
|
Smaller reporting company |
☐ |
|
|
|
Emerging growth company |
☐ |
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange
Act.
☐
Indicate by check mark whether the registrant is a shell company
(as defined in Rule 12b-2 of the Exchange Act). Yes
☐
No
☒
Number of shares of common stock, $.20 par value, outstanding as of
April 27, 2022: 265,193,412
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EX-101 INSTANCE DOCUMENT |
EX-101 SCHEMA DOCUMENT |
EX-101 CALCULATION LINKBASE DOCUMENT |
EX-101 LABELS LINKBASE DOCUMENT |
EX-101 PRESENTATION LINKBASE DOCUMENT |
EX-101 DEFINITION LINKBASE DOCUMENT |
Part I — FINANCIAL INFORMATION
Item 1.
Financial
Statements
W. R. BERKLEY CORPORATION AND SUBSIDIARIES CONSOLIDATED BALANCE
SHEETS
(In thousands, except share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31,
2022 |
|
December 31,
2021 |
|
(Unaudited) |
|
(Audited) |
Assets |
|
|
|
Investments: |
|
|
|
Fixed maturity securities (amortized cost of $16,838,703 and
$16,471,304; allowance for expected credit losses of $26,531 and
$22,625 at March 31, 2022 and December 31, 2021,
respectively)
|
$ |
16,426,196 |
|
|
$ |
16,602,673 |
|
Real estate |
1,276,157 |
|
|
1,852,508 |
|
Investment funds |
1,545,648 |
|
|
1,480,612 |
|
Arbitrage trading account |
1,188,910 |
|
|
1,179,606 |
|
Equity securities |
1,126,491 |
|
|
941,243 |
|
Loans receivable (net of allowance for expected credit losses of
$1,429 and $1,718 at March 31, 2022 and December 31,
2021, respectively)
|
115,097 |
|
|
115,172 |
|
|
|
|
|
Total investments |
21,678,499 |
|
|
22,171,814 |
|
Cash and cash equivalents |
2,114,841 |
|
|
1,568,843 |
|
Premiums and fees receivable (net of allowance for expected credit
losses of $28,236 and $25,218 at March 31, 2022 and
December 31, 2021, respectively)
|
2,599,357 |
|
|
2,522,972 |
|
Due from reinsurers (net of allowance for expected credit losses of
$7,655 and $7,713 at March 31, 2022 and December 31,
2021, respectively)
|
2,929,161 |
|
|
2,923,026 |
|
Deferred policy acquisition costs |
716,645 |
|
|
676,145 |
|
Prepaid reinsurance premiums |
680,703 |
|
|
676,915 |
|
|
|
|
|
Property, furniture and equipment |
417,888 |
|
|
419,883 |
|
Goodwill |
169,652 |
|
|
169,652 |
|
Accrued investment income |
129,194 |
|
|
122,938 |
|
Current and deferred federal and foreign income taxes |
43,527 |
|
|
42,457 |
|
|
|
|
|
Other assets |
771,487 |
|
|
753,231 |
|
Total assets |
$ |
32,250,954 |
|
|
$ |
32,047,876 |
|
|
|
|
|
Liabilities and Equity |
|
|
|
Liabilities: |
|
|
|
Reserves for losses and loss expenses |
$ |
15,722,889 |
|
|
$ |
15,390,888 |
|
Unearned premiums |
5,026,905 |
|
|
4,847,160 |
|
Due to reinsurers |
524,562 |
|
|
514,980 |
|
Trading account securities sold but not yet purchased |
241 |
|
|
1,169 |
|
Trading account payable to brokers and clearing
organizations |
56,652 |
|
|
53,636 |
|
|
|
|
|
|
|
|
|
Other liabilities |
1,189,919 |
|
|
1,305,245 |
|
Senior notes and other debt |
1,834,155 |
|
|
2,259,416 |
|
Subordinated debentures |
1,007,832 |
|
|
1,007,652 |
|
Total liabilities |
25,363,155 |
|
|
25,380,146 |
|
Equity: |
|
|
|
Preferred stock, par value $0.10 per share:
|
|
|
|
Authorized 5,000,000 shares; issued and outstanding -
none
|
— |
|
|
— |
|
Common stock, par value $0.20 per share:
|
|
|
|
Authorized 750,000,000 shares, issued and outstanding, net of
treasury shares, 265,186,251 and 265,170,882 shares,
respectively
|
105,803 |
|
|
105,803 |
|
Additional paid-in capital |
992,012 |
|
|
981,104 |
|
Retained earnings |
9,582,790 |
|
|
9,015,135 |
|
Accumulated other comprehensive loss |
(649,229) |
|
|
(281,955) |
|
Treasury stock, at cost, 263,828,377 and 263,843,868 shares,
respectively
|
(3,166,873) |
|
|
(3,167,076) |
|
Total stockholders’ equity |
6,864,503 |
|
|
6,653,011 |
|
Noncontrolling interests |
23,296 |
|
|
14,719 |
|
Total equity |
6,887,799 |
|
|
6,667,730 |
|
Total liabilities and equity |
$ |
32,250,954 |
|
|
$ |
32,047,876 |
|
See accompanying notes to interim consolidated financial
statements.
W. R. BERKLEY CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)
(In thousands, except per share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months
Ended March 31, |
|
|
|
|
|
2022 |
|
2021 |
|
|
|
|
REVENUES: |
|
|
|
|
|
|
|
Net premiums written |
$ |
2,413,254 |
|
|
$ |
2,050,038 |
|
|
|
|
|
Change in net unearned premiums |
(164,167) |
|
|
(200,082) |
|
|
|
|
|
Net premiums earned |
2,249,087 |
|
|
1,849,956 |
|
|
|
|
|
Net investment income |
173,512 |
|
|
158,577 |
|
|
|
|
|
Net investment gains: |
|
|
|
|
|
|
|
Net realized and unrealized gains on investments |
369,882 |
|
|
51,759 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in allowance for expected credit losses on
investments |
(3,617) |
|
|
(16,920) |
|
|
|
|
|
Net investment gains |
366,265 |
|
|
34,839 |
|
|
|
|
|
Revenues from non-insurance businesses |
97,776 |
|
|
87,430 |
|
|
|
|
|
Insurance service fees |
27,951 |
|
|
25,808 |
|
|
|
|
|
Other income |
818 |
|
|
259 |
|
|
|
|
|
Total revenues |
2,915,409 |
|
|
2,156,869 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OPERATING COSTS AND EXPENSES: |
|
|
|
|
|
|
|
Losses and loss expenses |
1,339,252 |
|
|
1,121,592 |
|
|
|
|
|
Other operating costs and expenses |
713,899 |
|
|
616,268 |
|
|
|
|
|
Expenses from non-insurance businesses |
94,855 |
|
|
86,290 |
|
|
|
|
|
Interest expense |
34,970 |
|
|
36,651 |
|
|
|
|
|
Total operating costs and expenses |
2,182,976 |
|
|
1,860,801 |
|
|
|
|
|
Income before income taxes |
732,433 |
|
|
296,068 |
|
|
|
|
|
Income tax expense |
(139,403) |
|
|
(64,352) |
|
|
|
|
|
Net income before noncontrolling interests |
593,030 |
|
|
231,716 |
|
|
|
|
|
Noncontrolling interests |
(2,392) |
|
|
(2,191) |
|
|
|
|
|
Net income to common stockholders |
$ |
590,638 |
|
|
$ |
229,525 |
|
|
|
|
|
|
|
|
|
|
|
|
|
NET INCOME PER SHARE: |
|
|
|
|
|
|
|
Basic |
$ |
2.13 |
|
|
$ |
0.83 |
|
|
|
|
|
Diluted |
$ |
2.12 |
|
|
$ |
0.82 |
|
|
|
|
|
See accompanying notes to interim consolidated financial
statements.
W. R. BERKLEY CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(UNAUDITED)
(In thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months
Ended March 31, |
|
|
|
|
|
2022 |
|
2021 |
|
|
|
|
Net income before noncontrolling interests |
$ |
593,030 |
|
|
$ |
231,716 |
|
|
|
|
|
Other comprehensive (loss) income: |
|
|
|
|
|
|
|
Change in unrealized currency translation adjustments |
56,272 |
|
|
4,050 |
|
|
|
|
|
Change in unrealized investment losses, net of taxes |
(423,545) |
|
|
(90,130) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive loss |
(367,273) |
|
|
(86,080) |
|
|
|
|
|
Comprehensive income |
225,757 |
|
|
145,636 |
|
|
|
|
|
Noncontrolling interests |
(2,391) |
|
|
(2,191) |
|
|
|
|
|
Comprehensive income to common stockholders |
$ |
223,366 |
|
|
$ |
143,445 |
|
|
|
|
|
See accompanying notes to interim consolidated financial
statements.
W. R. BERKLEY CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(UNAUDITED)
(In thousands, except per share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months
Ended March 31, |
|
|
|
|
2022 |
|
2021 |
|
|
|
|
COMMON STOCK: |
|
|
|
|
|
|
|
Beginning and end of period |
$ |
105,803 |
|
|
$ |
105,803 |
|
|
|
|
|
ADDITIONAL PAID-IN CAPITAL: |
|
|
|
|
|
|
|
Beginning of period |
$ |
981,104 |
|
|
$ |
977,215 |
|
|
|
|
|
Restricted stock units issued |
(530) |
|
|
(525) |
|
|
|
|
|
Restricted stock units expensed |
11,438 |
|
|
11,598 |
|
|
|
|
|
|
|
|
|
|
|
|
|
End of period |
$ |
992,012 |
|
|
$ |
988,288 |
|
|
|
|
|
RETAINED EARNINGS: |
|
|
|
|
|
|
|
Beginning of period |
$ |
9,015,135 |
|
|
$ |
8,348,381 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income to common stockholders |
590,638 |
|
|
229,525 |
|
|
|
|
|
Dividends ($0.09 and $0.08, per share, respectively)
|
(22,983) |
|
|
(21,285) |
|
|
|
|
|
End of period |
$ |
9,582,790 |
|
|
$ |
8,556,621 |
|
|
|
|
|
ACCUMULATED OTHER COMPREHENSIVE LOSS: |
|
|
|
|
|
|
|
Unrealized investment (loss) gains: |
|
|
|
|
|
|
|
Beginning of period |
$ |
90,900 |
|
|
$ |
289,714 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in unrealized losses on securities without an allowance for
expected credit losses |
(423,839) |
|
|
(100,485) |
|
|
|
|
|
Change in unrealized gains on securities with an allowance for
expected credit losses |
293 |
|
|
10,355 |
|
|
|
|
|
End of period |
(332,646) |
|
|
199,584 |
|
|
|
|
|
Currency translation adjustments: |
|
|
|
|
|
|
|
Beginning of period |
(372,855) |
|
|
(351,886) |
|
|
|
|
|
Net change in period |
56,272 |
|
|
4,050 |
|
|
|
|
|
End of period |
(316,583) |
|
|
(347,836) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total accumulated other comprehensive loss |
$ |
(649,229) |
|
|
$ |
(148,252) |
|
|
|
|
|
TREASURY STOCK: |
|
|
|
|
|
|
|
Beginning of period |
$ |
(3,167,076) |
|
|
$ |
(3,058,425) |
|
|
|
|
|
Stock exercised/vested |
203 |
|
|
248 |
|
|
|
|
|
Stock repurchased |
— |
|
|
(29,683) |
|
|
|
|
|
|
|
|
|
|
|
|
|
End of period |
$ |
(3,166,873) |
|
|
$ |
(3,087,860) |
|
|
|
|
|
NONCONTROLLING INTERESTS: |
|
|
|
|
|
|
|
Beginning of period |
$ |
14,719 |
|
|
$ |
14,995 |
|
|
|
|
|
Contributions (distributions) |
6,186 |
|
|
(1,502) |
|
|
|
|
|
Net income |
2,392 |
|
|
2,191 |
|
|
|
|
|
Other comprehensive loss, net of tax |
(1) |
|
|
— |
|
|
|
|
|
End of period |
$ |
23,296 |
|
|
$ |
15,684 |
|
|
|
|
|
See accompanying notes to interim consolidated financial
statements.
W. R. BERKLEY CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
(In thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months
Ended March 31, |
|
|
2022 |
|
2021 |
CASH FROM OPERATING ACTIVITIES: |
|
|
|
Net income to common stockholders |
$ |
590,638 |
|
|
$ |
229,525 |
|
Adjustments to reconcile net income to net cash from operating
activities: |
|
|
|
Net investment gains |
(366,265) |
|
|
(34,839) |
|
Depreciation and amortization |
24,631 |
|
|
33,543 |
|
Noncontrolling interests |
2,392 |
|
|
2,191 |
|
Investment funds |
(52,012) |
|
|
(38,935) |
|
Stock incentive plans |
11,438 |
|
|
11,817 |
|
Change in: |
|
|
|
Arbitrage trading account |
(7,215) |
|
|
(16,108) |
|
Premiums and fees receivable |
(69,704) |
|
|
(96,290) |
|
Reinsurance accounts |
(2,643) |
|
|
(105,589) |
|
Deferred policy acquisition costs |
(39,220) |
|
|
(38,577) |
|
Income taxes |
123,763 |
|
|
47,372 |
|
|
|
|
|
Reserves for losses and loss expenses |
316,065 |
|
|
303,305 |
|
Unearned premiums |
167,522 |
|
|
219,920 |
|
Other |
(221,708) |
|
|
(206,345) |
|
Net cash from operating activities |
477,682 |
|
|
310,990 |
|
CASH FROM (USED IN) INVESTING ACTIVITIES: |
|
|
|
Proceeds from sale of fixed maturity securities |
408,221 |
|
|
1,115,114 |
|
Proceeds from sale of equity securities |
9,227 |
|
|
57,457 |
|
(Contributions) distributions from investment funds |
(13,423) |
|
|
36,236 |
|
Proceeds from maturities and prepayments of fixed maturity
securities |
1,440,457 |
|
|
1,623,357 |
|
Purchase of fixed maturity securities |
(2,200,214) |
|
|
(4,118,161) |
|
Purchase of equity securities |
(100,356) |
|
|
(69,181) |
|
Real estate sold |
28,141 |
|
|
9,787 |
|
|
|
|
|
Change in loans receivable |
332 |
|
|
9,256 |
|
Net purchases of property, furniture and equipment |
(9,114) |
|
|
(10,872) |
|
Change in balances due to security brokers |
98,058 |
|
|
151,776 |
|
Cash received in connection with business disposition |
906,789 |
|
|
— |
|
Payment for business purchased net of cash acquired |
(49,572) |
|
|
— |
|
Other |
17 |
|
|
— |
|
Net cash from (used in) investing activities |
518,563 |
|
|
(1,195,231) |
|
CASH (USED IN) FROM FINANCING ACTIVITIES: |
|
|
|
Repayment of senior notes and other debt |
(426,503) |
|
|
(110,000) |
|
Net payments for stock options exercised |
(327) |
|
|
(525) |
|
Net proceeds from issuance of debt |
1,186 |
|
|
691,213 |
|
Cash dividends to common stockholders |
(22,983) |
|
|
(21,285) |
|
Purchase of common treasury shares |
— |
|
|
(29,683) |
|
Other, net |
(2,703) |
|
|
(1,503) |
|
Net cash (used in) from financing activities |
(451,330) |
|
|
528,217 |
|
Net impact on cash due to change in foreign exchange
rates |
1,083 |
|
|
(1,431) |
|
Net change in cash and cash equivalents |
545,998 |
|
|
(357,455) |
|
Cash and cash equivalents at beginning of period |
1,568,843 |
|
|
2,372,366 |
|
Cash and cash equivalents at end of period |
$ |
2,114,841 |
|
|
$ |
2,014,911 |
|
See accompanying notes to interim consolidated financial
statements.
W. R. Berkley Corporation and Subsidiaries
NOTES TO INTERIM CONSOLIDATED FINANCIAL STATEMENTS
(UNAUDITED)
(1) General
The unaudited consolidated financial
statements, which include the accounts of W. R. Berkley Corporation
and its subsidiaries (the “Company”), have been prepared on the
basis of U.S. generally accepted accounting principles (“GAAP”) for
interim financial information. Accordingly, they do not include all
the information and notes required by GAAP for annual financial
statements. The unaudited consolidated financial statements reflect
all adjustments, consisting only of normal recurring items, which
are necessary to present fairly the Company’s financial position
and results of operations on a basis consistent with the prior
audited consolidated financial statements. Operating results for
interim periods are not necessarily indicative of the results that
may be expected for the year. All significant intercompany accounts
and transactions have been eliminated. The preparation of financial
statements in conformity with GAAP requires management to make
estimates and assumptions that affect the reported amounts of
assets and liabilities and disclosures of contingent assets and
liabilities at the date of the financial statements and the
revenues and expenses reflected during the reporting period. For
further information related to areas of judgment and estimates and
other information necessary to understand the Company’s financial
position and results of operations, refer to the audited
consolidated financial statements and notes included in the
Company’s Annual Report on Form 10-K for the year ended
December 31, 2021.
Reclassifications have been made in the 2021 financial statements
as originally reported to conform to the presentation of the 2022
financial statements. Shares outstanding and per share amounts have
been adjusted to reflect the 3-for-2 common stock split effected on
March 23, 2022.
The income tax provision has been computed based on the Company’s
estimated annual effective tax rate. The effective income tax rate
differs from the federal income tax rate of 21% primarily due to a
net reduction to the Company’s valuation allowance against foreign
tax credits and foreign net operating losses, which was partially
offset by state income taxes.
(2) Per Share Data
The Company presents both basic and diluted
net income per share (“EPS”) amounts. Basic EPS is calculated by
dividing net income by the weighted average number of common shares
outstanding during the period (including 11,592,699 and 11,651,811
common shares held in a grantor trust as of March 31, 2022 and
2021, respectively). The common shares held in the grantor trust
are for delivery upon settlement of vested but mandatorily deferred
restricted stock units ("RSUs"). Shares held by the grantor trust
do not affect diluted shares outstanding since the shares
deliverable under vested RSUs were already included in diluted
shares outstanding. Diluted EPS is based upon the weighted average
number of basic and common equivalent shares outstanding during the
period and is calculated using the treasury stock method for stock
incentive plans. Common equivalent shares are excluded from the
computation in periods in which they have an anti-dilutive
effect.
The weighted average number of common
shares used in the computation of basic and diluted earnings per
share was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months
Ended March 31, |
|
|
|
|
(In thousands) |
2022 |
|
2021 |
|
|
|
|
Basic |
276,772 |
|
|
277,793 |
|
|
|
|
|
Diluted |
279,157 |
|
|
280,245 |
|
|
|
|
|
(3) Recent Accounting Pronouncements and Accounting
Policies
Recently adopted accounting pronouncements:
All accounting and reporting standards that
became effective in 2022 were either not applicable to the Company
or their adoption did not have a material impact on the
Company.
Accounting and reporting standards that are not yet
effective:
All recently issued but not yet effective
accounting and reporting standards are either not applicable to the
Company or are not expected to have a material impact on the
Company.
(4) Acquisitions
In March 2022, the Company acquired an 80.0% ownership interest for
$51.1 million in a company engaged in residential and
commercial textiles. The fair value of the assets acquired and
liabilities assumed have been estimated based on a preliminary
valuation. The fair values of the assets and liabilities will be
adjusted, as needed, following completion of the final
valuation.
The following table summarizes the initial
estimated fair value of net assets acquired and liabilities assumed
for the business combination completed in 2022:
|
|
|
|
|
|
(In thousands) |
2022 |
|
|
|
|
Cash and cash equivalents |
$ |
1,564 |
|
Real estate, furniture and equipment |
2,527 |
|
Intangible assets |
48,787 |
|
|
|
Other assets |
11,275 |
|
Total assets acquired |
64,153 |
|
|
|
Other liabilities assumed |
(5,417) |
|
Noncontrolling interest |
(7,600) |
|
|
|
Net assets acquired |
$ |
51,136 |
|
(5) Consolidated Statements of Comprehensive Income
The following table presents the components
of the changes in accumulated other comprehensive (loss) income
("AOCI"):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In thousands) |
Unrealized Investment Gains (Losses) |
|
Currency Translation Adjustments |
|
|
Accumulated Other Comprehensive
(Loss) Income |
As of and for the three months ended March 31, 2022 |
|
|
|
|
|
Changes in AOCI |
|
|
|
|
|
Beginning of period |
$ |
90,900 |
|
|
$ |
(372,855) |
|
|
|
$ |
(281,955) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive (loss) income before
reclassifications |
(433,136) |
|
|
56,272 |
|
|
|
(376,864) |
|
Amounts reclassified from AOCI |
9,591 |
|
|
— |
|
|
|
9,591 |
|
Other comprehensive (loss) income |
(423,545) |
|
|
56,272 |
|
|
|
(367,273) |
|
Unrealized investment gain related to noncontrolling
interest |
(1) |
|
|
— |
|
|
|
(1) |
|
End of period |
$ |
(332,646) |
|
|
$ |
(316,583) |
|
|
|
$ |
(649,229) |
|
Amounts reclassified from AOCI |
|
|
|
|
|
|
Pre-tax |
$ |
12,141 |
|
(1) |
$ |
— |
|
|
|
$ |
12,141 |
|
Tax effect |
(2,550) |
|
(2) |
— |
|
|
|
(2,550) |
|
After-tax amounts reclassified |
$ |
9,591 |
|
|
$ |
— |
|
|
|
$ |
9,591 |
|
Other comprehensive (loss) income |
|
|
|
|
|
|
Pre-tax |
$ |
(539,449) |
|
|
$ |
56,272 |
|
|
|
$ |
(483,177) |
|
Tax effect |
115,904 |
|
|
— |
|
|
|
115,904 |
|
Other comprehensive (loss) income |
$ |
(423,545) |
|
|
$ |
56,272 |
|
|
|
$ |
(367,273) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of and for the three months ended March 31, 2021 |
|
|
|
|
|
Changes in AOCI |
|
|
|
|
|
Beginning of period |
$ |
289,714 |
|
|
$ |
(351,886) |
|
|
|
$ |
(62,172) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other comprehensive (loss) income before
reclassifications |
(98,991) |
|
|
4,050 |
|
|
|
(94,941) |
|
Amounts reclassified from AOCI |
8,861 |
|
|
— |
|
|
|
8,861 |
|
Other comprehensive (loss) income |
(90,130) |
|
|
4,050 |
|
|
|
(86,080) |
|
Unrealized investment gain related to noncontrolling
interest |
— |
|
|
— |
|
|
|
— |
|
End of period |
$ |
199,584 |
|
|
$ |
(347,836) |
|
|
|
$ |
(148,252) |
|
Amounts reclassified from AOCI |
|
|
|
|
|
|
Pre-tax |
$ |
11,216 |
|
(1) |
$ |
— |
|
|
|
$ |
11,216 |
|
Tax effect |
(2,355) |
|
(2) |
— |
|
|
|
(2,355) |
|
After-tax amounts reclassified |
$ |
8,861 |
|
|
$ |
— |
|
|
|
$ |
8,861 |
|
Other comprehensive (loss) income |
|
|
|
|
|
|
Pre-tax |
$ |
(113,735) |
|
|
$ |
4,050 |
|
|
|
$ |
(109,685) |
|
Tax effect |
23,605 |
|
|
— |
|
|
|
23,605 |
|
Other comprehensive (loss) income |
$ |
(90,130) |
|
|
$ |
4,050 |
|
|
|
$ |
(86,080) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
____________
(1) Net investment gains (losses) in the consolidated statements of
income.
(2) Income tax expense in the consolidated statements of
income.
(6) Statements of Cash Flows
Interest payments were $52,899,000 and
$45,393,000 for the three months ended March 31, 2022 and 2021,
respectively. No income taxes were paid during such
periods.
(7) Investments in Fixed Maturity Securities
At March 31, 2022 and
December 31, 2021, investments in fixed maturity securities
were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In thousands) |
Amortized
Cost |
|
Allowance for Expected Credit Losses (1) |
|
Gross Unrealized |
|
Fair
Value |
|
Carrying
Value |
Gains |
|
Losses |
|
March 31, 2022 |
|
|
|
|
|
|
|
|
|
|
|
Held to maturity: |
|
|
|
|
|
|
|
|
|
|
|
State and municipal |
$ |
70,165 |
|
|
$ |
(378) |
|
|
$ |
7,094 |
|
|
$ |
— |
|
|
$ |
76,881 |
|
|
$ |
69,787 |
|
Residential mortgage-backed |
4,455 |
|
|
— |
|
|
324 |
|
|
— |
|
|
4,779 |
|
|
4,455 |
|
Total held to maturity |
74,620 |
|
|
(378) |
|
|
7,418 |
|
|
— |
|
|
81,660 |
|
|
74,242 |
|
Available for sale: |
|
|
|
|
|
|
|
|
|
|
|
U.S. government and government agency |
837,167 |
|
|
— |
|
|
2,397 |
|
|
(20,716) |
|
|
818,848 |
|
|
818,848 |
|
State and municipal: |
|
|
|
|
|
|
|
|
|
|
|
Special revenue |
1,948,586 |
|
|
— |
|
|
12,944 |
|
|
(44,803) |
|
|
1,916,727 |
|
|
1,916,727 |
|
State general obligation |
378,408 |
|
|
— |
|
|
7,043 |
|
|
(6,574) |
|
|
378,877 |
|
|
378,877 |
|
Pre-refunded |
165,882 |
|
|
— |
|
|
6,216 |
|
|
— |
|
|
172,098 |
|
|
172,098 |
|
Corporate backed |
175,070 |
|
|
— |
|
|
1,407 |
|
|
(4,472) |
|
|
172,005 |
|
|
172,005 |
|
Local general obligation |
410,058 |
|
|
— |
|
|
11,184 |
|
|
(5,075) |
|
|
416,167 |
|
|
416,167 |
|
Total state and municipal |
3,078,004 |
|
|
— |
|
|
38,794 |
|
|
(60,924) |
|
|
3,055,874 |
|
|
3,055,874 |
|
Mortgage-backed: |
|
|
|
|
|
|
|
|
|
|
|
Residential |
1,179,468 |
|
|
— |
|
|
2,417 |
|
|
(60,650) |
|
|
1,121,235 |
|
|
1,121,235 |
|
Commercial |
266,921 |
|
|
— |
|
|
339 |
|
|
(3,759) |
|
|
263,501 |
|
|
263,501 |
|
Total mortgage-backed |
1,446,389 |
|
|
— |
|
|
2,756 |
|
|
(64,409) |
|
|
1,384,736 |
|
|
1,384,736 |
|
Asset-backed |
4,319,535 |
|
|
— |
|
|
1,459 |
|
|
(63,573) |
|
|
4,257,421 |
|
|
4,257,421 |
|
Corporate: |
|
|
|
|
|
|
|
|
|
|
|
Industrial |
3,373,710 |
|
|
|
|
12,708 |
|
|
(115,614) |
|
|
3,270,804 |
|
|
3,270,804 |
|
Financial |
1,747,275 |
|
|
— |
|
|
4,612 |
|
|
(45,155) |
|
|
1,706,732 |
|
|
1,706,732 |
|
Utilities |
422,354 |
|
|
— |
|
|
1,806 |
|
|
(14,434) |
|
|
409,726 |
|
|
409,726 |
|
Other |
206,526 |
|
|
— |
|
|
47 |
|
|
(5,328) |
|
|
201,245 |
|
|
201,245 |
|
Total corporate |
5,749,865 |
|
|
— |
|
|
19,173 |
|
|
(180,531) |
|
|
5,588,507 |
|
|
5,588,507 |
|
Foreign government |
1,333,123 |
|
|
(26,153) |
|
|
3,411 |
|
|
(63,813) |
|
|
1,246,568 |
|
|
1,246,568 |
|
Total available for sale |
16,764,083 |
|
|
(26,153) |
|
|
67,990 |
|
|
(453,966) |
|
|
16,351,954 |
|
|
16,351,954 |
|
Total investments in fixed maturity securities |
$ |
16,838,703 |
|
|
$ |
(26,531) |
|
|
$ |
75,408 |
|
|
$ |
(453,966) |
|
|
$ |
16,433,614 |
|
|
$ |
16,426,196 |
|
____________
(1) Represents the amount of impairment that has resulted from
credit-related factors. The change in the allowance for expected
credit losses is recognized in the consolidated statements of
income. Amount excludes unrealized losses relating to non-credit
factors.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In thousands) |
Amortized
Cost |
|
Allowance for Expected Credit Losses (1) |
|
Gross Unrealized |
|
Fair
Value |
|
Carrying
Value |
|
|
|
Gains |
|
Losses |
|
|
December 31, 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Held to maturity: |
|
|
|
|
|
|
|
|
|
|
|
|
|
State and municipal |
$ |
69,539 |
|
|
$ |
(387) |
|
|
$ |
10,813 |
|
|
$ |
— |
|
|
$ |
79,965 |
|
|
$ |
69,152 |
|
|
|
Residential mortgage-backed |
4,829 |
|
|
— |
|
|
632 |
|
|
— |
|
|
5,461 |
|
|
4,829 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total held to maturity |
74,368 |
|
|
(387) |
|
|
11,445 |
|
|
— |
|
|
85,426 |
|
|
73,981 |
|
|
|
Available for sale: |
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. government and government agency |
851,128 |
|
|
— |
|
|
8,509 |
|
|
(4,294) |
|
|
855,343 |
|
|
855,343 |
|
|
|
State and municipal: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Special revenue |
2,016,382 |
|
|
— |
|
|
62,961 |
|
|
(5,706) |
|
|
2,073,637 |
|
|
2,073,637 |
|
|
|
State general obligation |
388,110 |
|
|
— |
|
|
23,152 |
|
|
(1,015) |
|
|
410,247 |
|
|
410,247 |
|
|
|
Pre-refunded |
202,633 |
|
|
— |
|
|
14,891 |
|
|
(574) |
|
|
216,950 |
|
|
216,950 |
|
|
|
Corporate backed |
166,943 |
|
|
— |
|
|
7,191 |
|
|
(1,532) |
|
|
172,602 |
|
|
172,602 |
|
|
|
Local general obligation |
401,974 |
|
|
— |
|
|
29,455 |
|
|
(732) |
|
|
430,697 |
|
|
430,697 |
|
|
|
Total state and municipal |
3,176,042 |
|
|
— |
|
|
137,650 |
|
|
(9,559) |
|
|
3,304,133 |
|
|
3,304,133 |
|
|
|
Mortgage-backed: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Residential |
940,744 |
|
|
— |
|
|
9,896 |
|
|
(11,321) |
|
|
939,319 |
|
|
939,319 |
|
|
|
Commercial |
125,709 |
|
|
— |
|
|
3,388 |
|
|
(341) |
|
|
128,756 |
|
|
128,756 |
|
|
|
Total mortgage-backed securities |
1,066,453 |
|
|
— |
|
|
13,284 |
|
|
(11,662) |
|
|
1,068,075 |
|
|
1,068,075 |
|
|
|
Asset-backed |
4,504,950 |
|
|
— |
|
|
4,409 |
|
|
(18,794) |
|
|
4,490,565 |
|
|
4,490,565 |
|
|
|
Corporate: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Industrial |
3,231,520 |
|
|
(16) |
|
|
62,751 |
|
|
(21,092) |
|
|
3,273,163 |
|
|
3,273,163 |
|
|
|
Financial |
1,739,282 |
|
|
— |
|
|
30,709 |
|
|
(6,591) |
|
|
1,763,400 |
|
|
1,763,400 |
|
|
|
Utilities |
396,242 |
|
|
— |
|
|
13,262 |
|
|
(3,202) |
|
|
406,302 |
|
|
406,302 |
|
|
|
Other |
154,210 |
|
|
— |
|
|
125 |
|
|
(1,525) |
|
|
152,810 |
|
|
152,810 |
|
|
|
Total corporate |
5,521,254 |
|
|
(16) |
|
|
106,847 |
|
|
(32,410) |
|
|
5,595,675 |
|
|
5,595,675 |
|
|
|
Foreign government |
1,277,109 |
|
|
(22,222) |
|
|
7,508 |
|
|
(47,494) |
|
|
1,214,901 |
|
|
1,214,901 |
|
|
|
Total available for sale |
16,396,936 |
|
|
(22,238) |
|
|
278,207 |
|
|
(124,213) |
|
|
16,528,692 |
|
|
16,528,692 |
|
|
|
Total investments in fixed maturity securities |
$ |
16,471,304 |
|
|
$ |
(22,625) |
|
|
$ |
289,652 |
|
|
$ |
(124,213) |
|
|
$ |
16,614,118 |
|
|
$ |
16,602,673 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
____________
(1) Represents the amount of impairment that has resulted from
credit-related factors. The change in the allowance for expected
credit losses is recognized in the consolidated statements of
income. Amount excludes unrealized losses relating to non-credit
factors.
The following table presents the rollforward of the allowance for
expected credit losses for held to maturity securities for the
three months ended March 31, 2022 and 2021:
|
|
|
|
|
|
|
|
|
|
|
|
(In thousands) |
2022 |
|
2021 |
Allowance for expected credit losses, beginning of
period |
$ |
387 |
|
|
$ |
798 |
|
|
|
|
|
Provision for expected credit losses |
(9) |
|
|
(68) |
|
Allowance for expected credit losses, end of period |
$ |
378 |
|
|
$ |
730 |
|
The following table presents the rollforward of the allowance for
expected credit losses for available for sale securities for the
three months ended March 31, 2022 and 2021:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2022 |
|
2021 |
(In thousands) |
Foreign Government |
|
Corporate |
|
Total |
|
Foreign Government |
|
Corporate |
|
Total |
Allowance for expected credit losses, beginning of
period |
$ |
22,222 |
|
|
$ |
16 |
|
|
$ |
22,238 |
|
|
$ |
1,264 |
|
|
$ |
518 |
|
|
$ |
1,782 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected credit losses on securities for which credit losses were
not previously recorded |
484 |
|
|
— |
|
|
484 |
|
|
18,990 |
|
|
16 |
|
|
19,006 |
|
Expected credit losses (gains) on securities for which credit
losses were previously recorded |
3,447 |
|
|
(16) |
|
|
3,431 |
|
|
(261) |
|
|
(513) |
|
|
(774) |
|
Reduction due to disposals |
— |
|
|
— |
|
|
— |
|
|
— |
|
|
(5) |
|
|
(5) |
|
Allowance for expected credit losses, end of period |
$ |
26,153 |
|
|
$ |
— |
|
|
$ |
26,153 |
|
|
$ |
19,993 |
|
|
$ |
16 |
|
|
$ |
20,009 |
|
During the three months ended March 31, 2022, the Company increased
the allowance for expected credit losses for available for sale
securities utilizing its credit loss assessment process and inputs
used in its credit loss model, primarily due
to foreign government securities. During the three months ended
March 31, 2021, the Company increased the allowance for expected
credit losses for available for sale securities primarily due to
foreign government securities that had no reserve in prior
periods.
The amortized cost and fair value of fixed maturity securities at
March 31, 2022, by contractual maturity, are shown below.
Actual maturities may differ from contractual maturities because
certain issuers may have the right to call or prepay obligations.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In thousands) |
Amortized
Cost (1) |
|
Fair
Value |
|
|
|
|
|
|
|
|
Due in one year or less |
$ |
1,472,865 |
|
|
$ |
1,461,188 |
|
|
|
|
|
|
|
|
|
Due after one year through five years |
7,903,303 |
|
|
7,756,952 |
|
|
|
|
|
|
|
|
|
Due after five years through ten years |
4,029,040 |
|
|
3,898,727 |
|
|
|
|
|
|
|
|
|
Due after ten years |
1,982,273 |
|
|
1,927,232 |
|
|
|
|
|
|
|
|
|
Mortgage-backed securities |
1,450,844 |
|
|
1,389,515 |
|
|
|
|
|
|
|
|
|
Total |
$ |
16,838,325 |
|
|
$ |
16,433,614 |
|
|
|
|
|
|
|
|
|
________________
(1) Amortized cost is reduced by the allowance for expected credit
losses of $378 thousand related to held to maturity
securities.
At March 31, 2022 and December 31, 2021, there were no
investments that exceeded 10% of common stockholders' equity, other
than investments in United States government and government agency
securities.
(8) Investments in Equity Securities
At March 31, 2022 and
December 31, 2021, investments in equity securities were as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In thousands) |
Cost |
|
Gross Unrealized |
|
Fair
Value |
|
Carrying
Value |
Gains |
|
Losses |
|
March 31, 2022 |
|
|
|
|
|
|
|
|
|
Common stocks |
$ |
699,566 |
|
|
$ |
191,842 |
|
|
$ |
(8,091) |
|
|
$ |
883,317 |
|
|
$ |
883,317 |
|
Preferred stocks |
262,513 |
|
|
2,917 |
|
|
(22,256) |
|
|
243,174 |
|
|
243,174 |
|
Total |
$ |
962,079 |
|
|
$ |
194,759 |
|
|
$ |
(30,347) |
|
|
$ |
1,126,491 |
|
|
$ |
1,126,491 |
|
|
|
|
|
|
|
|
|
|
|
December 31, 2021 |
|
|
|
|
|
|
|
|
|
Common stocks |
$ |
619,896 |
|
|
$ |
92,401 |
|
|
$ |
(16,894) |
|
|
$ |
695,403 |
|
|
$ |
695,403 |
|
Preferred stocks |
250,149 |
|
|
7,874 |
|
|
(12,183) |
|
|
245,840 |
|
|
245,840 |
|
Total |
$ |
870,045 |
|
|
$ |
100,275 |
|
|
$ |
(29,077) |
|
|
$ |
941,243 |
|
|
$ |
941,243 |
|
(9) Arbitrage Trading Account
At March 31, 2022 and
December 31, 2021, the fair and carrying values of the
arbitrage trading account were $1,189 million and $1,180 million,
respectively. The primary focus of the trading account is merger
arbitrage. Merger arbitrage is the business of investing in the
securities of publicly held companies which are the targets in
announced tender offers and mergers. Arbitrage investing differs
from other types of investing in its focus on transactions and
events believed likely to bring about a change in value over a
relatively short time period (usually four months or
less).
The Company uses put options and call
options in order to mitigate the impact of potential changes in
market conditions on the merger arbitrage trading account. These
options are reported at fair value. As of March 31, 2022, the
fair value of short option contracts outstanding was $242 thousand
(notional amount of $29.2 million). Other than with respect to the
use of these trading account securities, the Company does not make
use of derivatives.
(10) Net Investment Income
Net investment income consisted of the
following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months
Ended March 31, |
|
|
|
|
(In thousands) |
2022 |
|
2021 |
|
|
|
|
Investment income earned on: |
|
|
|
|
|
|
|
Fixed maturity securities, including cash and cash equivalents and
loans receivable |
$ |
101,284 |
|
|
$ |
94,677 |
|
|
|
|
|
Investment funds |
52,012 |
|
|
38,935 |
|
|
|
|
|
Arbitrage trading account |
9,187 |
|
|
19,074 |
|
|
|
|
|
Equity securities |
10,856 |
|
|
6,180 |
|
|
|
|
|
Real estate |
2,146 |
|
|
1,161 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross investment income |
175,485 |
|
|
160,027 |
|
|
|
|
|
Investment expense |
(1,973) |
|
|
(1,450) |
|
|
|
|
|
Net investment income |
$ |
173,512 |
|
|
$ |
158,577 |
|
|
|
|
|
(11) Investment Funds
The Company evaluates whether it is an
investor in a variable interest entity ("VIE"). Such entities do
not have sufficient equity at risk to finance their activities
without additional subordinated financial support, or the equity
investors, as a group, do not have the characteristics of a
controlling financial interest (primary beneficiary). The
Company determines whether it is the primary beneficiary of an
entity subject to consolidation based on a qualitative assessment
of the VIE's capital structure, contractual terms, nature of the
VIE's operations and purpose, and the Company's relative exposure
to the related risks of the VIE on the date it becomes initially
involved in the VIE and on an ongoing basis. The Company is not the
primary beneficiary in any of its investment funds, and
accordingly, carries its interests in investment funds under the
equity method of accounting.
The Company’s maximum exposure to loss with
respect to these investments is limited to the carrying amount
reported on the Company’s consolidated balance sheet and its
unfunded commitments, which were $615 million as of March 31,
2022.
Investment funds consisted of the
following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Carrying Value as of |
|
Income (Loss) from
Investment Funds |
|
March 31, |
|
December 31, |
|
For the Three Months
Ended March 31, |
(In thousands) |
2022 |
|
2021 |
|
2022 |
|
2021 |
Financial services |
$ |
454,701 |
|
|
$ |
431,818 |
|
|
$ |
25,932 |
|
|
$ |
17,142 |
|
Transportation |
341,022 |
|
|
336,688 |
|
|
11,179 |
|
|
6,228 |
|
Real Estate |
283,897 |
|
|
273,690 |
|
|
16,364 |
|
|
4,434 |
|
Energy |
136,401 |
|
|
150,224 |
|
|
(892) |
|
|
3,320 |
|
Other funds |
329,627 |
|
|
288,192 |
|
|
(569) |
|
|
7,811 |
|
Total |
$ |
1,545,648 |
|
|
$ |
1,480,612 |
|
|
$ |
52,014 |
|
|
$ |
38,935 |
|
The Company's share of the earnings or
losses from investment funds is generally reported on a one-quarter
lag in order to facilitate the timely completion of the Company's
consolidated financial statements.
Financial services investment funds include the Company’s minority
investment in Lifson Re, a Bermuda reinsurance company. Effective
January 1, 2021, Lifson Re participates on a fully collateralized
basis in a majority of the Company’s reinsurance placements for a
22.5% share of placed amounts. This pertains to all traditional
reinsurance/retrocessional placements for both property and
casualty business where there is more than one open market
reinsurer participating. For the three months ended March 31, 2022
and 2021, the Company has ceded approximately $89 million and
$53 million, respectively, of written premiums to Lifson
Re.
Other funds include deferred compensation trust assets of
$32 million and $34 million as of March 31, 2022 and
December 31, 2021, respectively. These assets support other
liabilities reflected in the balance sheet of an equal amount for
employees who have elected to defer a portion of their
compensation. The change in the net asset value of the trust is
recorded in other funds within net investment income with an
offsetting equal amount within corporate expenses.
(12) Real Estate
Investment in real estate represents
directly owned property held for investment, as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
Carrying Value |
|
March 31, |
|
December 31, |
(In thousands) |
2022 |
|
2021 |
Properties in operation |
$ |
1,052,198 |
|
|
$ |
1,626,826 |
|
Properties under development |
223,959 |
|
|
225,682 |
|
Total |
$ |
1,276,157 |
|
|
$ |
1,852,508 |
|
As of March 31, 2022, properties in
operation included a long-term ground lease in Washington, D.C., an
office complex in New York City and the completed portion of a
mixed-use project in Washington D.C. Properties in operation are
net of accumulated depreciation and amortization of $32,031,000 and
$57,391,000 as of March 31, 2022 and December 31, 2021,
respectively. Related depreciation expense was $4,788,000 and
$4,890,000 for the three months ended March 31, 2022 and 2021,
respectively. Future minimum rental income expected on operating
leases relating to properties in operation is
$24,004,686 in 2022, $30,750,724 in 2023, $30,466,934 in 2024,
$27,802,134 in 2025, $25,807,966 in 2026, $24,984,457 in 2027 and
$476,939,991 thereafter.
During the first quarter of 2022, the Company sold a real estate
investment in London.
A mixed-use project in Washington, D.C. has
been under development in 2022 and 2021, with the completed portion
reported in properties in operation as of March 31,
2022.
(13) Loans Receivable
At March 31, 2022 and December 31, 2021, loans receivable
were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
(In thousands) |
March 31,
2022 |
|
December 31,
2021 |
Amortized cost (net of allowance for expected credit
losses): |
|
|
|
Real estate loans |
$ |
89,213 |
|
|
$ |
89,431 |
|
Commercial loans |
25,884 |
|
|
25,741 |
|
Total |
$ |
115,097 |
|
|
$ |
115,172 |
|
|
|
|
|
Fair value: |
|
|
|
Real estate loans |
$ |
89,672 |
|
|
$ |
90,793 |
|
Commercial loans |
25,884 |
|
|
25,741 |
|
Total |
$ |
115,556 |
|
|
$ |
116,534 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The real estate loans are secured by commercial and residential
real estate primarily located in New York. These loans generally
earn interest at fixed or stepped interest rates and have
maturities through 2026. The commercial loans are with small
business owners who have secured the related financing with the
assets of the business. Commercial loans primarily earn interest on
a fixed basis and have varying maturities generally not exceeding
10 years.
Loans receivable in non-accrual status were none and $0.2 million
as of March 31, 2022 and December 31, 2021,
respectively.
The following table presents the rollforward of the allowance for
expected credit losses for loans receivable for the three months
ended March 31, 2022 and 2021:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2022 |
|
2021 |
(In thousands) |
Real Estate Loans |
|
Commercial Loans |
|
Total |
|
Real Estate Loans |
|
Commercial Loans |
|
Total |
Allowance for expected credit losses, beginning of
period |
$ |
1,362 |
|
|
$ |
356 |
|
|
$ |
1,718 |
|
|
$ |
1,683 |
|
|
$ |
3,754 |
|
|
$ |
5,437 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for expected credit losses |
(67) |
|
|
(222) |
|
|
(289) |
|
|
(75) |
|
|
(1,164) |
|
|
(1,239) |
|
Allowance for expected credit losses, end of period |
$ |
1,295 |
|
|
$ |
134 |
|
|
$ |
1,429 |
|
|
$ |
1,608 |
|
|
$ |
2,590 |
|
|
$ |
4,198 |
|
During the three months ended March 31, 2022, the Company reduced
the allowance primarily due to the decrease in the duration of the
loan portfolio.
The Company monitors the performance of its loans receivable and
assesses the ability of the borrower to pay principal and interest
based upon loan structure, underlying property values, cash flow
and related financial and operating performance of the property and
market conditions.
In evaluating the real estate loans, the
Company considers their credit quality indicators, including loan
to value ratios, which compare the outstanding loan amount to the
estimated value of the property, the borrower’s financial condition
and performance with respect to loan terms, the position in the
capital structure, the overall leverage in the capital structure
and other market conditions.
(14) Net Investment Gains (Losses)
Net investment
gains (losses) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months
Ended March 31, |
|
|
(In thousands) |
2022 |
|
2021 |
|
|
|
|
Net investment gains (losses): |
|
|
|
|
|
|
|
Fixed maturity securities: |
|
|
|
|
|
|
|
Gains |
$ |
1,705 |
|
|
$ |
8,240 |
|
|
|
|
|
Losses |
(2,984) |
|
|
(2,071) |
|
|
|
|
|
Equity securities (1): |
|
|
|
|
|
|
|
Net realized gains on investment sales |
905 |
|
|
8,572 |
|
|
|
|
|
Change in unrealized gains (losses) |
93,213 |
|
|
(24,335) |
|
|
|
|
|
Investment funds |
(2,162) |
|
|
47,671 |
|
|
|
|
|
Real estate (2) |
286,192 |
|
|
12,909 |
|
|
|
|
|
Loans receivable |
(32) |
|
|
— |
|
|
|
|
|
Other |
(6,955) |
|
|
773 |
|
|
|
|
|
Net realized and unrealized gains on investments in earnings before
allowance for expected credit losses |
369,882 |
|
|
51,759 |
|
|
|
|
|
Change in allowance for expected credit losses on
investments: |
|
|
|
|
|
|
|
Fixed maturity securities |
(3,906) |
|
|
(18,159) |
|
|
|
|
|
Loans receivable |
289 |
|
|
1,239 |
|
|
|
|
|
Change in allowance for expected credit losses on
investments |
(3,617) |
|
|
(16,920) |
|
|
|
|
|
Net investment gains |
366,265 |
|
|
34,839 |
|
|
|
|
|
Income tax expense |
(78,442) |
|
|
(5,887) |
|
|
|
|
|
After-tax net investment gains |
$ |
287,823 |
|
|
$ |
28,952 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in unrealized investment losses on available for sale
securities: |
|
|
|
|
|
|
|
Fixed maturity securities without allowance for expected credit
losses |
$ |
(540,263) |
|
|
$ |
(122,568) |
|
|
|
|
|
Fixed maturity securities with allowance for expected credit
losses |
293 |
|
|
10,355 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment funds |
469 |
|
|
(1,020) |
|
|
|
|
|
Other |
52 |
|
|
(502) |
|
|
|
|
|
Total change in unrealized investment losses |
(539,449) |
|
|
(113,735) |
|
|
|
|
|
Income tax benefit |
115,904 |
|
|
23,605 |
|
|
|
|
|
Noncontrolling interests |
(1) |
|
|
— |
|
|
|
|
|
After-tax change in unrealized investment losses of available for
sale securities |
$ |
(423,546) |
|
|
$ |
(90,130) |
|
|
|
|
|
______________________
(1) The net realized gains or losses on investment sales represent
the total gains or losses from the purchase dates of the equity
securities. The change in unrealized (losses) gains consists of two
components: (i) the reversal of the gain or loss recognized in
previous periods on equity securities sold and (ii) the change in
unrealized gain or loss resulting from mark-to-market adjustments
on equity securities still held.
(2) During March 2022, the Company realized a gain on the sale of a
real estate investment in London, U.K. of $251 million, net of
transaction expenses and the foreign currency impact, including the
reversal of the currency translation adjustment.
(15) Fixed Maturity Securities in an Unrealized Loss
Position
The following tables summarize all fixed
maturity securities in an unrealized loss position at
March 31, 2022 and December 31, 2021 by the length of
time those securities have been continuously in an unrealized loss
position:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less Than 12 Months |
|
12 Months or Greater |
|
Total |
(In thousands) |
Fair
Value |
|
Gross
Unrealized Losses |
|
Fair
Value |
|
Gross
Unrealized Losses |
|
Fair
Value |
|
Gross
Unrealized Losses |
March 31, 2022 |
|
|
|
|
|
|
|
|
|
|
|
U.S. government and government agency |
$ |
547,027 |
|
|
$ |
18,521 |
|
|
$ |
36,307 |
|
|
$ |
2,195 |
|
|
$ |
583,334 |
|
|
$ |
20,716 |
|
State and municipal |
1,360,055 |
|
|
51,579 |
|
|
95,853 |
|
|
9,345 |
|
|
1,455,908 |
|
|
60,924 |
|
Mortgage-backed |
1,069,979 |
|
|
49,408 |
|
|
140,480 |
|
|
15,001 |
|
|
1,210,459 |
|
|
64,409 |
|
Asset-backed |
3,898,607 |
|
|
61,254 |
|
|
186,663 |
|
|
2,319 |
|
|
4,085,270 |
|
|
63,573 |
|
Corporate |
3,805,020 |
|
|
148,708 |
|
|
381,306 |
|
|
31,823 |
|
|
4,186,326 |
|
|
180,531 |
|
Foreign government |
809,004 |
|
|
29,721 |
|
|
211,576 |
|
|
34,092 |
|
|
1,020,580 |
|
|
63,813 |
|
Fixed maturity securities |
$ |
11,489,692 |
|
|
$ |
359,191 |
|
|
$ |
1,052,185 |
|
|
$ |
94,775 |
|
|
$ |
12,541,877 |
|
|
$ |
453,966 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2021 |
|
|
|
|
|
|
|
|
|
|
|
U.S. government and government agency |
$ |
487,712 |
|
|
$ |
4,026 |
|
|
$ |
17,021 |
|
|
$ |
268 |
|
|
$ |
504,733 |
|
|
$ |
4,294 |
|
State and municipal |
502,333 |
|
|
7,403 |
|
|
29,547 |
|
|
2,156 |
|
|
531,880 |
|
|
9,559 |
|
Mortgage-backed |
558,751 |
|
|
6,900 |
|
|
106,130 |
|
|
4,762 |
|
|
664,881 |
|
|
11,662 |
|
Asset-backed |
3,832,944 |
|
|
18,503 |
|
|
75,385 |
|
|
291 |
|
|
3,908,329 |
|
|
18,794 |
|
Corporate |
2,582,860 |
|
|
29,322 |
|
|
51,095 |
|
|
3,088 |
|
|
2,633,955 |
|
|
32,410 |
|
Foreign government |
758,975 |
|
|
15,793 |
|
|
82,057 |
|
|
31,701 |
|
|
841,032 |
|
|
47,494 |
|
Fixed maturity securities |
$ |
8,723,575 |
|
|
$ |
81,947 |
|
|
$ |
361,235 |
|
|
$ |
42,266 |
|
|
$ |
9,084,810 |
|
|
$ |
124,213 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Substantially all of the securities in an
unrealized loss position are rated investment grade, except for the
securities in the foreign government classification. A
significant amount of the unrealized loss on foreign government
securities is the result of changes in currency exchange
rates.
A summary of the Company’s non-investment
grade fixed maturity securities that were in an unrealized loss
position at March 31, 2022 is presented in the table
below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
($ in thousands) |
Number of
Securities |
|
Aggregate
Fair Value |
|
Gross
Unrealized Loss |
Foreign government |
37 |
|
|
$ |
132,306 |
|
|
$ |
30,753 |
|
Corporate |
12 |
|
|
30,071 |
|
|
3,158 |
|
State and municipal |
1 |
|
|
13,583 |
|
|
1,422 |
|
Mortgage-backed |
7 |
|
|
1,785 |
|
|
48 |
|
Asset-backed |
1 |
|
|
37 |
|
|
5 |
|
Total |
58 |
|
|
$ |
177,782 |
|
|
$ |
35,386 |
|
For fixed maturity securities that
management does not intend to sell or to be required to sell, the
portion of the decline in value that is considered to be due to
credit factors is recognized in earnings, and the portion of the
decline in value that is considered to be due to non-credit factors
is recognized in other comprehensive income.
The Company has evaluated its fixed
maturity securities in an unrealized loss position and believes the
unrealized losses are due primarily to temporary market and
sector-related factors rather than to issuer-specific factors. None
of these securities are delinquent or in default under financial
covenants. Based on its assessment of these issuers, the Company
expects them to continue to meet their contractual payment
obligations as they become due.
(16)
Fair Value Measurements
The Company’s fixed maturity available for
sale securities, equity securities and its arbitrage trading
account securities are carried at fair value. Fair value is defined
as “the price that would be received to sell an asset or paid to
transfer a liability in an orderly transaction between market
participants at the measurement date.” The Company utilizes a fair
value hierarchy that prioritizes the inputs to valuation techniques
used to measure fair value into three broad levels, as
follows:
Level 1
- Quoted prices (unadjusted) in active markets for identical assets
or liabilities that the Company has the ability to access at the
measurement date.
Level 2
- Quoted prices for similar assets or valuations based on inputs
that are observable.
Level 3
- Estimates of fair value based on internal pricing methodologies
using unobservable inputs. Unobservable inputs are only used to
measure fair value to the extent that observable inputs are not
available.
Substantially all of the Company’s fixed
maturity securities were priced by independent pricing services.
The prices provided by the independent pricing services are
estimated based on observable market data in active markets
utilizing pricing models and processes, which may include benchmark
yields, reported trades, broker/dealer quotes, issuer spreads,
two-sided markets, benchmark securities, bids, offers, sector
groupings, matrix pricing and reference data. The pricing services
may prioritize inputs differently on any given day for any security
based on market conditions, and not all inputs are available for
each security evaluation on any given day. The pricing services
used by the Company have indicated that they will only produce an
estimate of fair value if objectively verifiable information is
available. The determination of whether markets are active or
inactive is based upon the volume and level of activity for a
particular asset class. The Company reviews the prices provided by
pricing services for reasonableness and periodically performs
independent price tests of a sample of securities to ensure proper
valuation.
If prices from independent pricing services
are not available for fixed maturity securities, the Company
estimates the fair value. For Level 2 securities, the Company
utilizes pricing models and processes which may include benchmark
yields, sector groupings, matrix pricing, reported trades,
broker/dealer quotes, issuer spreads, two-sided markets, bids,
offers and reference data. Where broker quotes are used, the
Company generally requests two or more quotes and sets a price
within the range of quotes received based on its assessment of the
credibility of the quote and its own evaluation of the security.
The Company generally does not adjust quotes received from brokers.
For securities traded only in private negotiations, the Company
determines fair value based primarily on the cost of such
securities, which is adjusted to reflect prices of recent
placements of securities of the same issuer, financial projections,
credit quality and business developments of the issuer and other
relevant information.
For Level 3 securities, the Company
generally uses a discounted cash flow model to estimate the fair
value of fixed maturity securities. The cash flow models are based
upon assumptions as to prevailing credit spreads, interest rate and
interest rate volatility, time to maturity and subordination
levels. Projected cash flows are discounted at rates that are
adjusted to reflect illiquidity, where appropriate.
The following tables present the assets and
liabilities measured at fair value on a recurring basis as of
March 31, 2022 and December 31, 2021 by
level:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In thousands) |
Total |
|
Level 1 |
|
Level 2 |
|
Level 3 |
March 31, 2022 |
|
|
|
|
|
|
|
Assets: |
|
|
|
|
|
|
|
Fixed maturity securities available for sale: |
|
|
|
|
|
|
|
U.S. government and government agency |
$ |
818,848 |
|
|
$ |
— |
|
|
$ |
818,848 |
|
|
$ |
— |
|
State and municipal |
3,055,874 |
|
|
— |
|
|
3,055,874 |
|
|
— |
|
Mortgage-backed |
1,384,736 |
|
|
— |
|
|
1,384,736 |
|
|
— |
|
Asset-backed |
4,257,421 |
|
|
— |
|
|
4,257,421 |
|
|
— |
|
Corporate |
5,588,507 |
|
|
— |
|
|
5,588,507 |
|
|
— |
|
Foreign government |
1,246,568 |
|
|
— |
|
|
1,246,568 |
|
|
— |
|
Total fixed maturity securities available for sale |
16,351,954 |
|
|
— |
|
|
16,351,954 |
|
|
— |
|
Equity securities: |
|
|
|
|
|
|
|
Common stocks |
883,317 |
|
|
877,387 |
|
|
1,230 |
|
|
4,700 |
|
Preferred stocks |
243,174 |
|
|
— |
|
|
231,203 |
|
|
11,971 |
|
Total equity securities |
1,126,491 |
|
|
877,387 |
|
|
232,433 |
|
|
16,671 |
|
Arbitrage trading account |
1,188,910 |
|
|
1,186,353 |
|
|
2,557 |
|
|
— |
|
Total |
$ |
18,667,355 |
|
|
$ |
2,063,740 |
|
|
$ |
16,586,944 |
|
|
$ |
16,671 |
|
Liabilities: |
|
|
|
|
|
|
|
Trading account securities sold but not yet purchased |
$ |
241 |
|
|
$ |
241 |
|
|
$ |
— |
|
|
$ |
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2021 |
|
|
|
|
|
|
|
Assets: |
|
|
|
|
|
|
|
Fixed maturity securities available for sale: |
|
|
|
|
|
|
|
U.S. government and government agency |
$ |
855,343 |
|
|
$ |
— |
|
|
$ |
855,343 |
|
|
$ |
— |
|
State and municipal |
3,304,133 |
|
|
— |
|
|
3,304,133 |
|
|
— |
|
Mortgage-backed |
1,068,075 |
|
|
— |
|
|
1,068,075 |
|
|
— |
|
Asset-backed |
4,490,565 |
|
|
— |
|
|
4,490,565 |
|
|
— |
|
Corporate |
5,595,675 |
|
|
— |
|
|
5,595,675 |
|
|
— |
|
Foreign government |
1,214,901 |
|
|
— |
|
|
1,214,901 |
|
|
— |
|
Total fixed maturity securities available for sale |
16,528,692 |
|
|
— |
|
|
16,528,692 |
|
|
— |
|
Equity securities: |
|
|
|
|
|
|
|
Common stocks |
695,403 |
|
|
684,470 |
|
|
1,639 |
|
|
9,294 |
|
Preferred stocks |
245,840 |
|
|
— |
|
|
234,544 |
|
|
11,296 |
|
Total equity securities |
941,243 |
|
|
684,470 |
|
|
236,183 |
|
|
20,590 |
|
Arbitrage trading account |
1,179,606 |
|
|
1,153,079 |
|
|
26,527 |
|
|
— |
|
Total |
$ |
18,649,541 |
|
|
$ |
1,837,549 |
|
|
$ |
16,791,402 |
|
|
$ |
20,590 |
|
Liabilities: |
|
|
|
|
|
|
|
Trading account securities sold but not yet purchased |
$ |
1,169 |
|
|
$ |
1,137 |
|
|
$ |
32 |
|
|
$ |
— |
|
The following tables summarize changes in
Level 3 assets and liabilities for the three months ended March 31,
2022 and for the year ended December 31, 2021:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gains (Losses) Included In: |
(In thousands) |
Beginning
Balance |
|
Earnings (Losses) |
|
Other
Comprehensive
Income (Losses) |
|
Impairments |
|
Purchases |
|
Sales |
|
Paydowns / Maturities |
|
Transfers In / (Out) |
|
Ending
Balance |
|
Three Months Ended March 31, 2022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stocks |
$ |
9,294 |
|
|
$ |
(4,594) |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
4,700 |
|
Preferred stocks |
11,296 |
|
|
— |
|
|
— |
|
|
— |
|
|
675 |
|
|
— |
|
|
— |
|
|
— |
|
|
11,971 |
|
Total |
20,590 |
|
|
(4,594) |
|
|
— |
|
|
— |
|
|
675 |
|
|
— |
|
|
— |
|
|
— |
|
|
16,671 |
|
Arbitrage trading account |
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
Total |
$ |
20,590 |
|
|
$ |
(4,594) |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
675 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
16,671 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trading account securities sold but not yet purchased |
$ |
— |
|
|
$ |
(1) |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
1 |
|
|
$ |
— |
|
Year Ended
December 31, 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturities securities available for sale: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate |
$ |
1,000 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
(1,000) |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
Total |
1,000 |
|
|
— |
|
|
— |
|
|
— |
|
|
— |
|
|
(1,000) |
|
|
— |
|
|
— |
|
|
— |
|
Equity securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stocks |
9,215 |
|
|
640 |
|
|
— |
|
|
— |
|
|
— |
|
|
(561) |
|
|
— |
|
|
— |
|
|
9,294 |
|
Preferred stocks |
9,331 |
|
|
(35) |
|
|
— |
|
|
— |
|
|
2,000 |
|
|
— |
|
|
— |
|
|
— |
|
|
11,296 |
|
Total |
18,546 |
|
|
605 |
|
|
— |
|
|
— |
|
|
2,000 |
|
|
(561) |
|
|
— |
|
|
— |
|
|
20,590 |
|
Arbitrage trading account |
— |
|
|
8 |
|
|
— |
|
|
— |
|
|
— |
|
|
(8) |
|
|
— |
|
|
— |
|
|
— |
|
Total |
$ |
19,546 |
|
|
$ |
613 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
2,000 |
|
|
$ |
(1,569) |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
20,590 |
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trading account securities sold but not yet purchased |
$ |
— |
|
|
$ |
1 |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
(1) |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
For the three months ended March 31, 2022,
there was one security transferred into Level 3. For the year ended
December 31, 2021, there were no securities transferred into
or out of Level 3.
(17) Reserves for Loss and Loss Expenses
The Company's reserves for losses and loss
expenses are comprised of case reserves and incurred but not
reported liabilities ("IBNR"). When a claim is reported, a case
reserve is established for the estimated ultimate payment based
upon known information about the claim. As more information about
the claim becomes available over time, case reserves are adjusted
up or down as appropriate. Reserves are also established on an
aggregate basis to provide for IBNR liabilities and expected loss
reserve development on reported claims.
Loss reserves included in the Company’s
financial statements represent management’s best estimates based
upon an actuarially derived point estimate and other
considerations. The Company uses a variety of actuarial techniques
and methods to derive an actuarial point estimate for each
operating unit. These methods include paid loss development,
incurred loss development, paid and incurred Bornhuetter-Ferguson
methods and frequency and severity methods. In circumstances where
one actuarial method is considered more credible than the others,
that method is used to set the point estimate. The actuarial point
estimate may also be based on a judgmental weighting of estimates
produced from each of the methods considered. Industry loss
experience is used to supplement the Company’s own data in
selecting “tail factors” in areas where the Company’s own data is
limited. The actuarial data is analyzed by line of business,
coverage and accident or policy year, as appropriate, for each
operating unit.
The establishment of the actuarially
derived loss reserve point estimate also includes consideration of
qualitative factors that may affect the ultimate losses. These
qualitative considerations include, among others, the impact of
re-underwriting initiatives, changes in the mix of business,
changes in distribution sources and changes in policy terms and
conditions.
The key assumptions used to arrive at the
best estimate of loss reserves are the expected loss ratios, rate
of loss cost inflation, and reported and paid loss emergence
patterns. Expected loss ratios represent management’s expectation
of losses at the time the business is priced and written, before
any actual claims experience has emerged. This expectation is a
significant determinant of the estimate of loss reserves for
recently written business where there is little paid or incurred
loss data to consider. Expected loss ratios are generally derived
from historical loss ratios adjusted for the impact of rate
changes, loss cost trends and known changes in the type of risks
underwritten. Expected loss ratios are estimated for each key line
of business within each operating unit. Expected loss cost
inflation is particularly important for the long-tail lines, such
as excess casualty, and claims with a high medical component, such
as workers’ compensation. Reported and paid loss emergence patterns
are used to project current reported or paid loss amounts to their
ultimate settlement value. Loss development factors are based on
the historical emergence patterns of paid and incurred losses, and
are derived from the Company’s own experience and industry data.
The paid loss emergence pattern is also significant to excess and
assumed workers’ compensation reserves because those reserves are
discounted to their estimated present value based upon such
estimated payout patterns.
Loss frequency and severity are measures of
loss activity that are considered in determining the key
assumptions described in our discussion of loss and loss expense
reserves, including expected loss ratios, rate of loss cost
inflation and reported and paid loss emergence patterns. Loss
frequency is a measure of the number of claims per unit of insured
exposure, and loss severity is a measure of the average size of
claims. Factors affecting loss frequency include the effectiveness
of loss controls and safety programs and changes in economic
activity or weather patterns. Factors affecting loss severity
include changes in policy limits, retentions, rate of inflation and
judicial interpretations.
Another factor affecting estimates of loss
frequency and severity is the loss reporting lag, which is the
period of time between the occurrence of a loss and the date the
loss is reported to the Company. The length of the loss reporting
lag affects our ability to accurately predict loss frequency (loss
frequencies are more predictable for lines with short reporting
lags) as well as the amount of reserves needed for incurred but not
reported losses (less IBNR is required for lines with short
reporting lags). As a result, loss reserves for lines with short
reporting lags are likely to have less variation from initial loss
estimates. For lines with short reporting lags, which include
commercial automobile, primary workers’ compensation, other
liability (claims-made) and property business, the key assumption
is the loss emergence pattern used to project ultimate loss
estimates from known losses paid or reported to date. For lines of
business with long reporting lags, which include other liability
(occurrence), products liability, excess workers’ compensation and
liability reinsurance, the key assumption is the expected loss
ratio since there is often little paid or incurred loss data to
consider. Historically, the Company has experienced less variation
from its initial loss estimates for lines of businesses with short
reporting lags than for lines of business with long reporting
lags.
The key assumptions used in calculating the
most recent estimate of the loss reserves are reviewed each quarter
and adjusted, to the extent necessary, to reflect the latest
reported loss data, current trends and other factors
observed.
The table below provides a reconciliation
of the beginning and ending reserve balances:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
(In thousands) |
2022 |
|
2021 |
|
|
Net reserves at beginning of period |
$ |
12,848,362 |
|
|
$ |
11,620,393 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net provision for losses and loss expenses: |
|
|
|
|
|
Claims occurring during the current year (1) |
1,327,695 |
|
|
1,115,173 |
|
|
|
Increase (decrease) in estimates for claims occurring in prior
years (2) (3) |
3,761 |
|
|
(859) |
|
|
|
Loss reserve discount accretion |
7,796 |
|
|
7,278 |
|
|
|
Total |
1,339,252 |
|
|
1,121,592 |
|
|
|
Net payments for claims: |
|
|
|
|
|
Current year |
84,598 |
|
|
97,586 |
|
|
|
Prior years |
933,656 |
|
|
794,472 |
|
|
|
Total |
1,018,254 |
|
|
892,058 |
|
|
|
Foreign currency translation |
9,983 |
|
|
(14,779) |
|
|
|
Net reserves at end of period |
13,179,343 |
|
|
11,835,148 |
|
|
|
Ceded reserves at end of period |
2,543,546 |
|
|
2,245,380 |
|
|
|
Gross reserves at end of period |
$ |
15,722,889 |
|
|
$ |
14,080,528 |
|
|
|
_______________________________________
(1) Claims occurring during the current year are net of loss
reserve discounts of $7 million and $5 million for the three months
ended March 31, 2022 and 2021, respectively.
(2) The change in estimates for claims occurring in prior years is
net of loss reserve discount. On an undiscounted basis, the
estimates for claims occurring in prior years decreased by $4
million and $5 million for the three months ended March 31, 2022
and 2021, respectively.
(3) For certain retrospectively rated insurance policies and
reinsurance agreements, reserve development is offset by additional
or return premiums. Favorable development, net of additional and
return premiums, was $1 million and $3 million for the three months
ended March 31, 2022 and 2021, respectively.
The COVID-19 global pandemic has impacted, and may further impact,
the Company’s results through its effect on claim frequency and
severity. Loss cost trends have been impacted and may be further
impacted by COVID-19-related claims in certain lines of business.
Losses incurred from COVID-19-related claims have been offset, to a
certain extent, by lower claim frequency in certain lines of our
businesses; however, as the economy and legal systems have
reopened, the benefit of lower claim frequency has continued to
abate. Although as populations continue to be vaccinated against
the virus and the effects of the pandemic have receded in many
jurisdictions, most particularly the United States, it remains too
early to determine the ultimate net impact of COVID-19 on the
Company. New variants of the COVID-19 virus, including the
“Omicron” variant, continue to create risks with respect to loss
costs and the potential for renewed impact of the other effects of
COVID-19 associated with economic conditions, inflation, and social
distancing and work from home rules.
Most of the COVID-19-related claims reported to the Company to date
involve certain short-tailed lines of business, including
contingency and event cancellation, business interruption, and film
production delay. The Company has also received COVID-19-related
claims for longer-tailed casualty lines of business such as
workers’ compensation and other liability; however, the estimated
incurred loss impact for these reported claims are not material at
this time. Given the continuing uncertainty regarding the
pandemic's pervasiveness, the future impact that the pandemic may
have on claim frequency and severity remains uncertain at this
time.
The Company has estimated the potential COVID-19 impact to its
contingency and event cancellation, workers’ compensation, and
other lines of business under a number of possible scenarios;
however, due to COVID-19’s continued evolving impact, there remains
a high degree of uncertainty around the Company’s COVID-19
reserves. In addition, should the pandemic continue or worsen as a
result of new COVID-19 variants or otherwise, governments in the
jurisdictions where we operate may renew their efforts to expand
policy coverage terms beyond the policy’s intended coverage.
Accordingly, losses arising from these actions, and the other
factors described above, could exceed the Company’s reserves
established for those related policies.
As of March 31, 2022, the Company had recognized losses for
COVID-19-related claims activity, net of reinsurance, of
approximately $290 million, of which $246 million relates
to the Insurance segment and $44 million relates to the
Reinsurance & Monoline Excess segment. Such $290 million
of COVID-19-related losses included $268 million of reported
losses and $22 million of IBNR. For the three months ended
March 31, 2022, the Company recognized current accident year losses
for COVID-19-related claims activity, net of reinsurance, of
approximately $1 million, which relates to the Insurance
segment.
During the three months ended March 31, 2022, favorable prior year
development (net of additional and return premiums) of $1 million
included $6 million of favorable development for the Insurance
segment, largely offset by $5 million of adverse development for
the Reinsurance & Monoline Excess segment.
The overall favorable development for the Insurance segment was
primarily attributable to favorable development on the 2021
accident year, largely offset by adverse development on the 2015
through 2019 accident years. The favorable development on the 2021
accident year was concentrated in the commercial auto liability,
other liability and accident and health (employer stop loss) lines
of business. The Company continued to experience lower reported
claim frequency in commercial auto and other liability in 2021
relative to historical averages, and lower reported incurred losses
relative to our expectations. These trends began in 2020, and were
likely caused by the impacts of the COVID-19 pandemic, including,
for example, lockdowns, reduced driving/traffic, significant work
from home, court closures, and similar reduced activities and
travel. While reported claim frequency in these lines increased in
2021 relative to 2020, it remained below the historical levels pre-
the start of the COVID-19 pandemic. Due to the ongoing uncertainty
regarding the ultimate impacts of the COVID-19 pandemic on accident
year 2021 incurred losses, the Company remains cautious in
factoring in these trends in setting its initial loss ratio picks
for this year. As accident year 2021 has begun to mature, we have
recognized some of the favorable reported experience in our
ultimate loss picks made as of March 31, 2022. The adverse
development on the 2015 through 2019 accident years is concentrated
in the other liability line of business, and to a lesser degree
professional liability and commercial auto liability. The
development is driven by a larger than expected number of large
losses reported. The large losses particularly impacted the excess
and surplus lines casualty classes of business.
The overall adverse development for the Reinsurance & Monoline
Excess segment was driven mainly by adverse development in the
non-proportional reinsurance assumed liability and professional
liability lines of business, largely offset by favorable
development in excess workers' compensation. Both the adverse and
favorable development was spread across many prior accident years.
The adverse development was associated primarily with our U.S.
assumed reinsurance business, and related to accounts insuring
construction projects and professional liability exposures. The
favorable excess workers' compensation development was driven by
continued lower claim frequency and reported losses relative to our
expectations and to favorable claim settlements.
During the three months ended March 31, 2021, favorable prior year
development (net of additional and return premiums) of
$3 million included $6 million of favorable development
for the Insurance segment, partially offset by $3 million of
adverse development for the Reinsurance & Monoline Excess
segment.
The overall favorable development for the Insurance segment was
primarily attributable to favorable development on the 2020
accident year, partially offset by adverse development on the 2016
through 2018 accident years. The favorable development on the 2020
accident year was largely concentrated in the commercial auto
liability and other liability lines of business. During 2020, the
Company achieved larger rate increases in these lines of business
than were contemplated in its budget and initial loss ratio
selections. The Company also experienced significantly lower
reported claim frequency in these lines in 2020 relative to
historical averages, and lower reported incurred losses relative to
our expectations. We believe that the lower claim frequency and
lower reported incurred losses were caused by the impacts of the
COVID-19 pandemic, including for example, lockdowns, reduced
driving and traffic, work from home, court closures, etc.; however,
due to the ongoing uncertainty regarding the ultimate impacts of
the pandemic on accident year 2020 incurred losses, the Company did
not adjust its reserves based on these lower trends during 2020. As
of March 31, 2021, we began to recognize some of the favorable
accident year 2020 experience in certain lines in our ultimate loss
picks. The adverse development on the 2016 through 2018 accident
years is concentrated in the other liability line of business, and
is driven by a higher than expected number of large losses
reported. The large losses particularly impacted directors and
officers liability and excess and surplus lines casualty classes of
business.
Prior year reserve development for the Reinsurance & Monoline
Excess segment was less significant during the first quarter of
2021, and consisted of small adverse or favorable movements across
many lines of business, which largely offset each other. The
largest contributor to the slight overall adverse development for
the segment was non-proportional reinsurance assumed property
business, which was impacted by higher than expected reported
losses on property per risk treaties written in the U.S. and U.K.
related to accident year 2020.
(18) Fair Value of Financial Instruments
The following table presents the carrying
amounts and estimated fair values of the Company’s financial
instruments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2022 |
|
December 31, 2021 |
(In thousands) |
Carrying Value |
|
Fair Value |
|
Carrying Value |
|
Fair Value |
Assets: |
|
|
|
|
|
|
|
Fixed maturity securities |
$ |
16,426,196 |
|
|
$ |
16,433,614 |
|
|
$ |
16,602,673 |
|
|
$ |
16,614,118 |
|
Equity securities |
|